Any feedback?
Please rate this page
(organism.php)
(0/150)

BRENDA support

Information on Organism Mus musculus

Synonyms:
Balb/c mouse; house mouse; LK3 transgenic mice; mouse; Mus musculus Linnaeus, 1758; Mus musculus; Mus sp. 129SV; nude mice; transgenic mice; Mus muscaris; mice C57BL/6xCBA/CaJ hybrid;
TaxTree of Organism Mus musculus
Condensed Tree View
cellular organisms (cellular root)
Eukaryota can be found in Brenda BRENDA pathways(domain)
Opisthokonta can be found in Brenda BRENDA pathways(clade)
Metazoa can be found in Brenda BRENDA pathways(kingdom)
Eumetazoa can be found in Brenda BRENDA pathways(clade)
Bilateria can be found in Brenda BRENDA pathways(clade)
Deuterostomia can be found in Brenda BRENDA pathways(clade)
Chordata can be found in Brenda BRENDA pathways(phylum)
Craniata can be found in Brenda (subphylum)
Vertebrata can be found in Brenda BRENDA pathways(clade)
Gnathostomata can be found in Brenda BRENDA pathways(clade)
Teleostomi can be found in Brenda (clade)
Euteleostomi can be found in Brenda BRENDA pathways(clade)
Sarcopterygii can be found in Brenda BRENDA pathways(superclass)
Dipnotetrapodomorpha can be found in Brenda (clade)
Tetrapoda can be found in Brenda BRENDA pathways(clade)
Amniota can be found in Brenda BRENDA pathways(clade)
Mammalia can be found in Brenda BRENDA pathways(class)
Theria can be found in Brenda BRENDA pathways(clade)
Eutheria can be found in Brenda BRENDA pathways(clade)
Boreoeutheria can be found in Brenda BRENDA pathways(clade)
Euarchontoglires can be found in Brenda BRENDA pathways(superorder)
Glires can be found in Brenda BRENDA pathways(clade)
Rodentia can be found in Brenda BRENDA pathways(order)
Myomorpha can be found in Brenda BRENDA pathways(suborder)
Muroidea can be found in Brenda BRENDA pathways(clade)
Muridae can be found in Brenda BRENDA pathways(family)
Murinae can be found in Brenda BRENDA pathways(subfamily)
Mus can be found in Brenda (genus)
Mus can be found in Brenda (subgenus)
Mus musculus can be found in Brenda BRENDA pathways(species)
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
top print hide
EC NUMBER
COMMENTARY hide
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
deleted, replaced by EC 3.4.21.122
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
transferred to EC 5.6.2.5, RNA 5'-3' helicase, EC 5.6.2.6, RNA 3'-5' helicase and EC 5.6.2.7, DEAD-box RNA helicase
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
preliminary BRENDA-supplied EC number
top print hide
PATHWAY
BRENDA Link
KEGG Link
MetaCyc Link
(-)-maackiain biosynthesis
-
-
PWY-2464
(-)-medicarpin biosynthesis
-
-
PWY-2463
(1'S,5'S)-averufin biosynthesis
-
-
PWY-5954
(1,4)-beta-D-xylan degradation
-
-
PWY-6717
(3R)-linalool biosynthesis
-
-
PWY-7709
(3R)-N-[(2S)-1-hydroxy-6-[(3R)-3-isocyanobutanamido]hexan-2-yl]-3-isocyanobutanamide biosynthesis
-
-
PWY-8320
(3S)-linalool biosynthesis
-
-
PWY-7141
(4R)-carvone biosynthesis
-
-
PWY-5928
(4S)-carvone biosynthesis
-
-
PWY-7443
(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoate biosynthesis II (4-desaturase)
-
-
PWY-7728
(4Z,7Z,10Z,13Z,16Z)-docosapentaenoate biosynthesis (6-desaturase)
-
-
PWY-7726
(5R)-carbapenem carboxylate biosynthesis
(5Z)-dodecenoate biosynthesis I
-
-
PWY0-862
(5Z)-dodecenoate biosynthesis II
-
-
PWY-7858
(5Z)-icosenoate biosynthesis
-
-
PWY-5361
(7Z,10Z,13Z)-hexadecatrienoate biosynthesis
-
-
PWY-7590
(8E,10E)-dodeca-8,10-dienol biosynthesis
-
-
PWY-7654
(9Z)-tricosene biosynthesis
-
-
PWY-7035
(aminomethyl)phosphonate degradation
-
-
PWY-7805
(Kdo)2-lipid A biosynthesis (E. coli)
-
-
KDO-LIPASYN-PWY
(Kdo)2-lipid A biosynthesis (generic)
-
-
PWY-8285
(Kdo)2-lipid A biosynthesis (H. pylori)
-
-
PWY2DNV-2
(Kdo)2-lipid A biosynthesis (P. gingivalis)
-
-
PWY-8247
(Kdo)2-lipid A biosynthesis (P. putida)
-
-
PWY-8075
(Kdo)2-lipid A biosynthesis I (Brucella)
-
-
PWY2B4Q-7
(Kdo)2-lipid A modification (H. pylori)
-
-
PWY2DNV-3
(R)- and (S)-3-hydroxybutanoate biosynthesis (engineered)
-
-
PWY-7216
(R)-camphor degradation
-
-
P601-PWY
(R)-cysteate degradation
-
-
PWY-6642
(S)-camphor degradation
-
-
PWY-6989
(S)-lactate fermentation to propanoate, acetate and hydrogen
-
-
PWY-8086
(S)-propane-1,2-diol degradation
-
-
PWY-7013
(S)-reticuline biosynthesis
-
-
(S)-reticuline biosynthesis I
-
-
PWY-3581
(S)-reticuline biosynthesis II
-
-
PWY-6133
(Z)-butanethial-S-oxide biosynthesis
-
-
PWY-6900
(Z)-phenylmethanethial S-oxide biosynthesis
-
-
PWY-6539
1,2-dichloroethane degradation
-
-
12DICHLORETHDEG-PWY
1,3-beta-D-glucan biosynthesis
-
-
PWY-6773
1,3-dimethylbenzene degradation to 3-methylbenzoate
-
-
PWY-5428
1,3-propanediol biosynthesis (engineered)
-
-
PWY-7385
1,4-dichlorobenzene degradation
-
-
14DICHLORBENZDEG-PWY
1,4-dimethylbenzene degradation to 4-methylbenzoate
-
-
PWY-5429
1,5-anhydrofructose degradation
-
-
PWY-6992
1-butanol autotrophic biosynthesis (engineered)
-
-
PWY-6886
1-methylpyrrolinium biosynthesis
-
-
PWY-5315
10-cis-heptadecenoyl-CoA degradation (yeast)
-
-
PWY-7337
10-trans-heptadecenoyl-CoA degradation (MFE-dependent, yeast)
-
-
PWY-7339
10-trans-heptadecenoyl-CoA degradation (reductase-dependent, yeast)
-
-
PWY-7338
11-cis-3-hydroxyretinal biosynthesis
-
-
PWY-7043
11-oxyandrogens biosynthesis
-
-
PWY-8202
15-epi-lipoxin biosynthesis
-
-
PWY66-393
1D-myo-inositol hexakisphosphate biosynthesis I (from Ins(1,4,5)P3)
-
-
PWY-6361
1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)
-
-
PWY-6362
1D-myo-inositol hexakisphosphate biosynthesis III (Spirodela polyrrhiza)
-
-
PWY-4661
1D-myo-inositol hexakisphosphate biosynthesis IV (Dictyostelium)
-
-
PWY-6372
1D-myo-inositol hexakisphosphate biosynthesis V (from Ins(1,3,4)P3)
-
-
PWY-6554
2'-deoxymugineic acid phytosiderophore biosynthesis
-
-
PWY-5912
2,2'-dihydroxybiphenyl degradation
-
-
PWY-7009
2,3-dihydroxybenzoate biosynthesis
-
-
PWY-5901
2,3-dihydroxybenzoate degradation
-
-
PWY-7480
2-amino-3-carboxymuconate semialdehyde degradation to 2-hydroxypentadienoate
-
-
PWY-5654
2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA
-
-
PWY-5652
2-amino-3-hydroxycyclopent-2-enone biosynthesis
-
-
PWY-7536
2-arachidonoylglycerol biosynthesis
-
-
PWY-8052
2-carboxy-1,4-naphthoquinol biosynthesis
-
-
PWY-5837
2-deoxy-alpha-D-ribose 1-phosphate degradation
-
-
PWY-7180
2-deoxy-D-glucose 6-phosphate degradation
-
-
PWY-8121
2-deoxy-D-ribose degradation I
-
-
PWY-8060
2-deoxy-D-ribose degradation II
-
-
PWY-8058
2-hydroxybiphenyl degradation
-
-
PWY-7008
2-methyl-branched fatty acid beta-oxidation
-
-
PWY-8181
2-methylcitrate cycle I
-
-
PWY0-42
2-methylcitrate cycle II
-
-
PWY-5747
2-methylpropene degradation
-
-
PWY-7778
2-nitrobenzoate degradation I
-
-
PWY-5647
2-nitrotoluene degradation
-
-
PWY-5641
2-oxobutanoate degradation I
-
-
PWY-5130
2-oxobutanoate degradation II
-
-
2OXOBUTYRATECAT-PWY
2-oxoglutarate decarboxylation to succinyl-CoA
-
-
PWY-5084
2-oxoisovalerate decarboxylation to isobutanoyl-CoA
-
-
PWY-5046
24-epi-campesterol, fucosterol, and clionasterol biosynthesis (diatoms)
-
-
PWY-8238
3,3'-disulfanediyldipropannoate degradation
-
-
PWY-7462
3,3'-thiodipropanoate degradation
-
-
PWY-7465
3,4,6-trichlorocatechol degradation
-
-
PWY-6094
3,5-dichlorocatechol degradation
-
-
PWY-6084
3,5-dimethoxytoluene biosynthesis
-
-
PWY-7076
3,8-divinyl-chlorophyllide a biosynthesis I (aerobic, light-dependent)
-
-
CHLOROPHYLL-SYN
3,8-divinyl-chlorophyllide a biosynthesis II (anaerobic)
-
-
PWY-5531
3,8-divinyl-chlorophyllide a biosynthesis III (aerobic, light independent)
-
-
PWY-7159
3-(4-hydroxyphenyl)pyruvate biosynthesis
-
-
PWY-5886
3-(imidazol-5-yl)lactate salvage
-
-
PWY-5029
3-chlorocatechol degradation
-
-
3-chlorocatechol degradation I (ortho)
-
-
PWY-6089
3-chlorocatechol degradation II (ortho)
-
-
PWY-6193
3-chlorocatechol degradation III (meta pathway)
-
-
PWY-6214
3-chlorotoluene degradation II
-
-
PWY-6104
3-dehydroquinate biosynthesis II (archaea)
-
-
PWY-6160
3-hydroxy-4-methyl-anthranilate biosynthesis I
-
-
PWY-7717
3-hydroxy-4-methyl-anthranilate biosynthesis II
-
-
PWY-7765
3-hydroxypropanoate cycle
-
-
PWY-5743
3-hydroxypropanoate/4-hydroxybutanate cycle
-
-
PWY-5789
3-hydroxyquinaldate biosynthesis
-
-
PWY-7733
3-methyl-branched fatty acid alpha-oxidation
-
-
PWY66-387
3-methylarginine biosynthesis
-
-
PWY-6511
3-methylbutanol biosynthesis (engineered)
-
-
PWY-6871
3-methylthiopropanoate biosynthesis
-
-
PWY-5389
3-phenylpropanoate degradation
-
-
P281-PWY
3-phenylpropionate degradation
-
-
3-phosphoinositide biosynthesis
-
-
PWY-6352
3-phosphoinositide degradation
-
-
PWY-6368
4,5-dichlorocatechol degradation
-
-
PWY-6093
4-amino-2-methyl-5-diphosphomethylpyrimidine biosynthesis II
-
-
PWY-7282
4-amino-3-hydroxybenzoate degradation
-
-
PWY-7006
4-aminobutanoate degradation I
-
-
PWY-6535
4-aminobutanoate degradation II
-
-
PWY-6537
4-aminobutanoate degradation III
-
-
PWY-6536
4-aminobutanoate degradation IV
-
-
PWY-6473
4-aminobutanoate degradation V
-
-
PWY-5022
4-chlorobenzoate degradation
-
-
PWY-6215
4-chlorocatechol degradation
-
-
PWY-6087
4-chloronitrobenzene degradation
-
-
PWY-5645
4-coumarate degradation (aerobic)
-
-
PWY-8002
4-coumarate degradation (anaerobic)
-
-
PWY-7046
4-deoxy-L-threo-hex-4-enopyranuronate degradation
-
-
PWY-6507
4-ethylphenol degradation (anaerobic)
-
-
PWY-6080
4-hydroxy-2(1H)-quinolone biosynthesis
-
-
PWY-6661
4-hydroxy-2-nonenal detoxification
-
-
PWY-7112
4-hydroxy-3-prenylbenzoate biosynthesis
-
-
PWY-7303
4-hydroxybenzoate biosynthesis I (eukaryotes)
-
-
PWY-5754
4-hydroxybenzoate biosynthesis III (plants)
-
-
PWY-6435
4-hydroxymandelate degradation
4-hydroxyphenylacetate degradation
4-methylphenol degradation to protocatechuate
-
-
PWY-7700
4-nitrophenol degradation I
-
-
PWY-5487
4-nitrophenol degradation II
-
-
PWY-5488
4-oxopentanoate degradation
-
-
PWY-7948
5'-deoxyadenosine degradation I
-
-
PWY-8130
5'-deoxyadenosine degradation II
-
-
PWY-8131
5,6-dimethylbenzimidazole biosynthesis I (aerobic)
-
-
PWY-5523
5-aminoimidazole ribonucleotide biosynthesis I
-
-
PWY-6121
5-aminoimidazole ribonucleotide biosynthesis II
-
-
PWY-6122
5-nitroanthranilate degradation
-
-
PWY-7044
5-oxo-L-proline metabolism
-
-
PWY-7942
6-gingerol analog biosynthesis (engineered)
-
-
PWY-6920
6-hydroxymethyl-dihydropterin diphosphate biosynthesis
-
-
6-hydroxymethyl-dihydropterin diphosphate biosynthesis I
-
-
PWY-6147
6-hydroxymethyl-dihydropterin diphosphate biosynthesis III (Chlamydia)
-
-
PWY-7539
6-hydroxymethyl-dihydropterin diphosphate biosynthesis IV (Plasmodium)
-
-
PWY-7852
7-(3-amino-3-carboxypropyl)-wyosine biosynthesis
-
-
PWY-7286
7-dehydroporiferasterol biosynthesis
-
-
PWY-7155
8-amino-7-oxononanoate biosynthesis I
-
-
PWY-6519
8-amino-7-oxononanoate biosynthesis IV
-
-
PWY-8203
8-oxo-(d)GTP detoxification I
-
-
PWY-6502
9-cis, 11-trans-octadecadienoyl-CoA degradation (isomerase-dependent, yeast)
-
-
PWY-7340
9-lipoxygenase and 9-allene oxide synthase pathway
-
-
PWY-5407
9-lipoxygenase and 9-hydroperoxide lyase pathway
-
-
PWY-5408
ABH and Lewis epitopes biosynthesis from type 1 precursor disaccharide
-
-
PWY-7832
ABH and Lewis epitopes biosynthesis from type 2 precursor disaccharide
-
-
PWY-7831
abscisic acid biosynthesis
-
-
PWY-695
Ac/N-end rule pathway
-
-
PWY-7800
Acarbose and validamycin biosynthesis
-
-
acetaldehyde biosynthesis I
-
-
PWY-6333
acetaldehyde biosynthesis II
-
-
PWY-6330
acetate and ATP formation from acetyl-CoA I
-
-
PWY0-1312
acetate and ATP formation from acetyl-CoA II
-
-
PWY-5535
acetate and ATP formation from acetyl-CoA III
-
-
PWY-8328
acetate conversion to acetyl-CoA
-
-
PWY0-1313
acetate fermentation
-
-
acetoacetate degradation (to acetyl CoA)
-
-
ACETOACETATE-DEG-PWY
acetoin degradation
-
-
acetone degradation I (to methylglyoxal)
-
-
PWY-5451
acetone degradation II (to acetoacetate)
-
-
PWY-5533
acetone degradation III (to propane-1,2-diol)
-
-
PWY-7466
acetyl CoA biosynthesis
-
-
acetyl-CoA biosynthesis from citrate
-
-
PWY-5172
acetyl-CoA fermentation to butanoate
-
-
PWY-5676
acetylene degradation (anaerobic)
-
-
P161-PWY
acridone alkaloid biosynthesis
-
-
PWY-5958
acrylate degradation I
-
-
PWY-6373
acrylate degradation II
-
-
PWY-8180
acrylonitrile degradation I
-
-
PWY-7308
acyl carrier protein activation
-
-
PWY-6012-1
acyl carrier protein metabolism
-
-
PWY-6012
acyl-CoA hydrolysis
-
-
PWY-5148
acyl-[acyl-carrier protein] thioesterase pathway
-
-
PWY-5142
acylceramide biosynthesis and processing
-
-
PWY-8042
adenine and adenosine salvage I
-
-
P121-PWY
adenine and adenosine salvage II
-
-
PWY-6605
adenine and adenosine salvage III
-
-
PWY-6609
adenine and adenosine salvage V
-
-
PWY-6611
adenine and adenosine salvage VI
-
-
PWY-6619
adenine salvage
-
-
PWY-6610
adenosine deoxyribonucleotides de novo biosynthesis I
-
-
PWY-7227
adenosine deoxyribonucleotides de novo biosynthesis II
-
-
PWY-7220
adenosine nucleotides degradation I
-
-
PWY-6596
adenosine nucleotides degradation II
-
-
SALVADEHYPOX-PWY
adenosine ribonucleotides de novo biosynthesis
-
-
PWY-7219
adipate biosynthesis
-
-
PWY-8347
adipate degradation
adlupulone and adhumulone biosynthesis
-
-
PWY-7857
aerobic respiration I (cytochrome c)
-
-
PWY-3781
aerobic respiration II (cytochrome c) (yeast)
-
-
PWY-7279
aerobic respiration III (alternative oxidase pathway)
-
-
PWY-4302
aerobic toluene degradation
-
-
Aflatoxin biosynthesis
-
-
aflatoxin biosynthesis
-
-
agarose degradation
-
-
PWY-6816
ajmaline and sarpagine biosynthesis
-
-
PWY-5301
alanine metabolism
-
-
alanine racemization
-
-
PWY-8072
Alanine, aspartate and glutamate metabolism
-
-
aldoxime degradation
-
-
P345-PWY
alginate degradation
-
-
PWY-6986
alkane biosynthesis I
-
-
PWY-7032
alkane biosynthesis II
-
-
PWY-7033
alkane oxidation
-
-
PWY-2724
all-trans-farnesol biosynthesis
-
-
PWY-6859
allantoin degradation
-
-
allantoin degradation to glyoxylate I
-
-
PWY-5694
allantoin degradation to glyoxylate III
-
-
PWY-5705
allantoin degradation to ureidoglycolate I (urea producing)
-
-
PWY-5697
allantoin degradation to ureidoglycolate II (ammonia producing)
-
-
PWY-5698
alliin metabolism
-
-
PWY-5706
allopregnanolone biosynthesis
-
-
PWY-7455
alpha-amyrin biosynthesis
-
-
PWY-5377
alpha-dystroglycan glycosylation
-
-
PWY-7981
alpha-linolenate biosynthesis I (plants and red algae)
-
-
PWY-5997
alpha-linolenate metabolites biosynthesis
-
-
PWY-8398
alpha-Linolenic acid metabolism
-
-
alpha-tocopherol degradation
-
-
PWY-6377
alpha-tomatine degradation
-
-
PWY18C3-5
Amaryllidacea alkaloids biosynthesis
-
-
PWY-7826
Amino sugar and nucleotide sugar metabolism
-
-
Aminoacyl-tRNA biosynthesis
-
-
Aminobenzoate degradation
-
-
aminopropanol phosphate biosynthesis II
-
-
PWY-7378
aminopropylcadaverine biosynthesis
-
-
PWY0-1303
ammonia assimilation cycle I
-
-
PWY-6963
ammonia assimilation cycle II
-
-
PWY-6964
ammonia assimilation cycle III
-
-
AMMASSIM-PWY
ammonia oxidation II (anaerobic)
-
-
P303-PWY
amygdalin and prunasin degradation
-
-
PWY-6011
anaerobic energy metabolism (invertebrates, cytosol)
-
-
PWY-7383
anaerobic energy metabolism (invertebrates, mitochondrial)
-
-
PWY-7384
anandamide biosynthesis I
-
-
PWY-8051
anandamide biosynthesis II
-
-
PWY-8053
anandamide degradation
-
-
PWY6666-1
anandamide lipoxygenation
-
-
PWY-8056
anapleurotic synthesis of oxalacetate
-
-
androgen and estrogen metabolism
-
-
androgen biosynthesis
-
-
PWY66-378
androstenedione degradation I (aerobic)
-
-
PWY-6944
androstenedione degradation II (anaerobic)
-
-
PWY-8152
ansatrienin biosynthesis
-
-
PWY-8040
anteiso-branched-chain fatty acid biosynthesis
-
-
PWY-8173
anthocyanin biosynthesis
-
-
PWY-5125
anthocyanin biosynthesis (pelargonidin 3-O-glucoside)
-
-
PWY-7267
apratoxin A biosynthesis
-
-
PWY-8361
Arabinogalactan biosynthesis - Mycobacterium
-
-
arachidonate biosynthesis
-
-
arachidonate biosynthesis I (6-desaturase, lower eukaryotes)
-
-
PWY-5353
arachidonate biosynthesis III (6-desaturase, mammals)
-
-
PWY-7592
arachidonate biosynthesis IV (8-detaturase, lower eukaryotes)
-
-
PWY-7601
arachidonate biosynthesis V (8-detaturase, mammals)
-
-
PWY-7725
arachidonate metabolites biosynthesis
-
-
PWY-8397
Arachidonic acid metabolism
-
-
arachidonic acid metabolism
-
-
Arg/N-end rule pathway (eukaryotic)
-
-
PWY-7799
Arginine and proline metabolism
-
-
Arginine biosynthesis
-
-
arginine dependent acid resistance
-
-
PWY0-1299
arginine metabolism
-
-
aromatic glucosinolate activation
-
-
PWY-6684
aromatic biogenic amine degradation (bacteria)
-
-
PWY-7431
aromatic polyketides biosynthesis
-
-
PWY-6316
arsenate detoxification I
-
-
PWY-8264
arsenate detoxification II
-
-
PWY-8101
arsenate detoxification III
-
-
PWY-8263
arsenate detoxification IV (mycothiol)
-
-
PWY-6421
arsenic detoxification (mammals)
-
-
PWY-4202
arsenic detoxification (plants)
-
-
PWY-8259
arsenic detoxification (yeast)
-
-
PWY-4621
arsenite to oxygen electron transfer
-
-
PWY-4521
arsenite to oxygen electron transfer (via azurin)
-
-
PWY-7429
Ascorbate and aldarate metabolism
-
-
ascorbate glutathione cycle
-
-
PWY-2261
ascorbate metabolism
-
-
ascorbate recycling (cytosolic)
-
-
PWY-6370
aspartate and asparagine metabolism
-
-
aspirin triggered resolvin D biosynthesis
-
-
PWY66-395
aspirin triggered resolvin E biosynthesis
-
-
PWY66-394
assimilatory sulfate reduction I
-
-
SO4ASSIM-PWY
assimilatory sulfate reduction II
-
-
SULFMETII-PWY
assimilatory sulfate reduction III
-
-
PWY-6683
assimilatory sulfate reduction IV
-
-
PWY1ZNC-1
astaxanthin biosynthesis (bacteria, fungi, algae)
-
-
PWY-5288
ATP biosynthesis
-
-
PWY-7980
Atrazine degradation
-
-
atromentin biosynthesis
-
-
PWY-7518
autoinducer AI-1 biosynthesis
-
-
PWY-6157
autoinducer AI-2 biosynthesis I
-
-
PWY-6153
autoinducer AI-2 biosynthesis II (Vibrio)
-
-
PWY-6154
avenanthramide biosynthesis
-
-
PWY-8157
bacilysin biosynthesis
-
-
PWY-7626
backdoor pathway of androgen biosynthesis
-
-
PWY-8200
bacterial bioluminescence
-
-
PWY-7723
baicalein degradation (hydrogen peroxide detoxification)
-
-
PWY-7214
baicalein metabolism
-
-
PWY-7212
baumannoferrin biosynthesis
-
-
PWY-7988
benzene degradation I (aerobic)
-
-
PWY-5450
benzoate biosynthesis I (CoA-dependent, beta-oxidative)
-
-
PWY-6443
benzoate biosynthesis II (CoA-independent, non-beta-oxidative)
-
-
PWY-6444
benzoate biosynthesis III (CoA-dependent, non-beta-oxidative)
-
-
PWY-6446
Benzoate degradation
-
-
Benzoxazinoid biosynthesis
-
-
benzoxazinoid glucosides biosynthesis
-
-
benzoyl-CoA biosynthesis
-
-
PWY-6458
benzoyl-CoA degradation
-
-
benzoyl-CoA degradation I (aerobic)
-
-
PWY-1361
berberine biosynthesis
-
-
PWY-3901
bergamotene biosynthesis I
-
-
PWY-6243
beta-(1,4)-mannan degradation
-
-
PWY-7456
beta-1,4-D-mannosyl-N-acetyl-D-glucosamine degradation
-
-
PWY-7586
beta-alanine biosynthesis I
-
-
PWY-3981
beta-alanine biosynthesis II
-
-
PWY-3941
beta-alanine biosynthesis III
-
-
PWY-5155
beta-alanine biosynthesis IV
-
-
PWY-5760
beta-alanine degradation I
-
-
BETA-ALA-DEGRADATION-I-PWY
beta-alanine degradation II
-
-
PWY-1781
beta-Alanine metabolism
-
-
beta-carboline biosynthesis
-
-
PWY-5877
beta-D-glucuronide and D-glucuronate degradation
-
-
PWY-7247
beta-D-mannosyl phosphomycoketide biosynthesis
-
-
PWY-7740
Betalain biosynthesis
-
-
betalamic acid biosynthesis
-
-
PWY-5394
betanidin degradation
-
-
PWY-5461
betaxanthin biosynthesis
-
-
PWY-5426
betaxanthin biosynthesis (via dopamine)
-
-
PWY-5403
Bifidobacterium shunt
-
-
P124-PWY
bile acid biosynthesis, neutral pathway
bile acids deconjugation
-
-
PWY-8135
Biosynthesis of 12-, 14- and 16-membered macrolides
-
-
Biosynthesis of ansamycins
-
-
Biosynthesis of enediyne antibiotics
-
-
biosynthesis of Lewis epitopes (H. pylori)
-
-
PWY-7833
Biosynthesis of secondary metabolites
-
-
Biosynthesis of siderophore group nonribosomal peptides
-
-
Biosynthesis of unsaturated fatty acids
-
-
Biosynthesis of vancomycin group antibiotics
-
-
Biosynthesis of various secondary metabolites - part 1
-
-
Biosynthesis of various secondary metabolites - part 3
-
-
biotin biosynthesis
-
-
biotin biosynthesis from 8-amino-7-oxononanoate I
-
-
PWY0-1507
Biotin metabolism
-
-
biotin-carboxyl carrier protein assembly
-
-
PWY0-1264
biphenyl degradation
-
-
PWY5F9-12
bis(guanylyl molybdopterin) cofactor sulfurylation
-
-
PWY-8164
bisabolene biosynthesis (engineered)
-
-
PWY-7102
bisphenol A degradation
-
-
PWY-7757
Bisphenol degradation
-
-
bisucaberin biosynthesis
-
-
PWY-6381
bombykol biosynthesis
-
-
PWY-7423
brassicicene C biosynthesis
-
-
PWY-7517
brassinolide biosynthesis I
-
-
PWY-699
brassinolide biosynthesis II
-
-
PWY-2582
Brassinosteroid biosynthesis
-
-
bryostatin biosynthesis
-
-
PWY-8047
bupropion degradation
-
-
PWY66-241
butachlor degradation
-
-
PWY-7771
butanoate fermentation
-
-
Butanoate metabolism
-
-
butanol and isobutanol biosynthesis (engineered)
-
-
PWY-7396
C20 prostanoid biosynthesis
-
-
PWY66-374
C20,20 CDP-archaeol biosynthesis
-
-
PWY-6349
C25,25 CDP-archaeol biosynthesis
-
-
PWY-8365
C30 carotenoid biosynthesis
-
-
C4 and CAM-carbon fixation
-
-
C4 photosynthetic carbon assimilation cycle, NAD-ME type
-
-
PWY-7115
C4 photosynthetic carbon assimilation cycle, NADP-ME type
-
-
PWY-241
C4 photosynthetic carbon assimilation cycle, PEPCK type
-
-
PWY-7117
C5-Branched dibasic acid metabolism
-
-
cadaverine biosynthesis
-
-
PWY0-1601
caffeine biosynthesis I
-
-
PWY-5037
caffeine biosynthesis II (via paraxanthine)
-
-
PWY-5038
caffeine degradation III (bacteria, via demethylation)
-
-
PWY-6538
Caffeine metabolism
-
-
Calvin-Benson-Bassham cycle
-
-
CALVIN-PWY
camalexin biosynthesis
-
-
CAMALEXIN-SYN
camphor degradation
-
-
canavanine biosynthesis
-
-
PWY-5
canavanine degradation
-
-
PWY-31
cannabinoid biosynthesis
-
-
PWY-5140
Caprolactam degradation
-
-
capsaicin biosynthesis
-
-
PWY-5710
capsiconiate biosynthesis
-
-
PWY-6027
Carbapenem biosynthesis
-
-
carbaryl degradation
-
-
PWY-8111
carbazole degradation
-
-
PWY-6550
carbofuran degradation I
-
-
PWY-8286
carbofuran degradation II
-
-
PWY-8287
carbofuran degradation III
-
-
PWY-8288
Carbon fixation in photosynthetic organisms
-
-
Carbon fixation pathways in prokaryotes
-
-
cardenolide glucosides biosynthesis
-
-
PWY-6036
cardiolipin and phosphatidylethanolamine biosynthesis (Xanthomonas)
-
-
PWY-7509
cardiolipin biosynthesis
-
-
cardiolipin biosynthesis I
-
-
PWY-5668
cardiolipin biosynthesis II
-
-
PWY-5269
cardiolipin biosynthesis III
-
-
PWY0-1545
carnitine metabolism
-
-
carnosine biosynthesis
-
-
PWY66-420
Carotenoid biosynthesis
-
-
carotenoid biosynthesis
-
-
carotenoid cleavage
-
-
PWY-6806
catechol degradation to 2-hydroxypentadienoate I
-
-
P183-PWY
catechol degradation to 2-hydroxypentadienoate II
-
-
PWY-5419
catechol degradation to beta-ketoadipate
-
-
CATECHOL-ORTHO-CLEAVAGE-PWY
catecholamine biosynthesis
CDP-6-deoxy-D-gulose biosynthesis
-
-
PWY-8139
CDP-diacylglycerol biosynthesis
-
-
CDP-diacylglycerol biosynthesis I
-
-
PWY-5667
CDP-diacylglycerol biosynthesis II
-
-
PWY0-1319
CDP-diacylglycerol biosynthesis III
-
-
PWY-5981
cell-surface glycoconjugate-linked phosphocholine biosynthesis
-
-
PWY-7886
cellulose and hemicellulose degradation (cellulolosome)
-
-
PWY-6784
cellulose biosynthesis
-
-
PWY-1001
cellulose degradation
-
-
cellulose degradation II (fungi)
-
-
PWY-6788
ceramide and sphingolipid recycling and degradation (yeast)
-
-
PWY-7119
ceramide biosynthesis
-
-
ceramide de novo biosynthesis
-
-
PWY3DJ-12
ceramide degradation (generic)
-
-
PWY-6483
ceramide degradation by alpha-oxidation
-
-
PWY66-388
chanoclavine I aldehyde biosynthesis
-
-
PWY-6493
chelerythrine biosynthesis
-
-
PWY-7507
chitin biosynthesis
-
-
PWY-6981
chitin deacetylation
-
-
PWY-7118
chitin degradation I (archaea)
-
-
PWY-6855
chitin degradation II (Vibrio)
-
-
PWY-6902
chitin degradation III (Serratia)
-
-
PWY-7822
chitin derivatives degradation
-
-
PWY-6906
chlorinated phenols degradation
-
-
PWY-6197
Chloroalkane and chloroalkene degradation
-
-
Chlorocyclohexane and chlorobenzene degradation
-
-
chlorogenic acid biosynthesis I
-
-
PWY-6039
chlorogenic acid degradation
-
-
PWY-6781
chlorophyll metabolism
-
-
chlorosalicylate degradation
-
-
PWY-6107
chlorpyrifos degradation
-
-
PWY-8065
cholesterol biosynthesis
-
-
cholesterol biosynthesis (algae, late side-chain reductase)
-
-
PWY-8191
cholesterol biosynthesis (diatoms)
-
-
PWY-8239
cholesterol biosynthesis (plants, early side-chain reductase)
-
-
PWY18C3-1
cholesterol biosynthesis I
-
-
PWY66-341
cholesterol biosynthesis II (via 24,25-dihydrolanosterol)
-
-
PWY66-3
cholesterol biosynthesis III (via desmosterol)
-
-
PWY66-4
cholesterol degradation to androstenedione I (cholesterol oxidase)
-
-
PWY-6945
cholesterol degradation to androstenedione II (cholesterol dehydrogenase)
-
-
PWY-6946
cholesterol degradation to androstenedione III (anaerobic)
-
-
PWY-8151
choline biosynthesis I
-
-
PWY-3385
choline biosynthesis III
-
-
PWY-3561
choline degradation I
-
-
CHOLINE-BETAINE-ANA-PWY
choline degradation III
-
-
PWY-7167
chondroitin biosynthesis
-
-
PWY-6566
chondroitin sulfate biosynthesis
-
-
PWY-6567
chondroitin sulfate degradation I (bacterial)
-
-
PWY-6572
chorismate biosynthesis from 3-dehydroquinate
-
-
PWY-6163
chorismate metabolism
-
-
cinnamoyl-CoA biosynthesis
-
-
PWY-6457
cis-abienol biosynthesis
-
-
PWY18C3-13
cis-geranyl-CoA degradation
-
-
PWY-6672
cis-vaccenate biosynthesis
cis-zeatin biosynthesis
-
-
PWY-2781
Citrate cycle (TCA cycle)
-
-
citric acid cycle
-
-
CMP phosphorylation
-
-
PWY-7205
CMP-2-keto-3-deoxy-D-glycero-D-galacto-nononate biosynthesis
-
-
PWY-6140
CMP-3-deoxy-D-manno-octulosonate biosynthesis
-
-
PWY-1269
CMP-8-amino-3,8-dideoxy-D-manno-octulosonate biosynthesis
-
-
PWY-7674
CMP-diacetamido-8-epilegionaminic acid biosynthesis
-
-
PWY-7719
CMP-KDO biosynthesis
-
-
CMP-legionaminate biosynthesis I
-
-
PWY-6749
CMP-N-acetylneuraminate biosynthesis I (eukaryotes)
-
-
PWY-6138
CMP-N-acetylneuraminate biosynthesis II (bacteria)
-
-
PWY-6139
CMP-N-glycoloylneuraminate biosynthesis
-
-
PWY-6144
CMP-pseudaminate biosynthesis
-
-
PWY-6143
CO2 fixation in Crenarchaeota
-
-
CO2 fixation into oxaloacetate (anaplerotic)
-
-
PWYQT-4429
cobalamin salvage (eukaryotic)
-
-
PWY-7974
coenzyme A biosynthesis I (bacteria)
-
-
COA-PWY
coenzyme A biosynthesis II (eukaryotic)
-
-
PWY-7851
coenzyme A biosynthesis III (archaea)
-
-
PWY-8342
coenzyme A metabolism
-
-
coenzyme B biosynthesis
-
-
P241-PWY
coenzyme M biosynthesis
-
-
coenzyme M biosynthesis I
-
-
P261-PWY
coenzyme M biosynthesis II
-
-
PWY-6643
colanic acid building blocks biosynthesis
-
-
COLANSYN-PWY
colupulone and cohumulone biosynthesis
-
-
PWY-5133
complex N-linked glycan biosynthesis (plants)
-
-
PWY-7920
complex N-linked glycan biosynthesis (vertebrates)
-
-
PWY-7426
conversion of succinate to propanoate
-
-
PWY0-43
coptisine biosynthesis
-
-
PWY-8030
coumarin biosynthesis (via 2-coumarate)
-
-
PWY-5176
coumarins biosynthesis (engineered)
-
-
PWY-7398
creatine biosynthesis
-
-
GLYCGREAT-PWY
creatine phosphate biosynthesis
-
-
PWY-6158
creatinine degradation
-
-
creatinine degradation I
-
-
CRNFORCAT-PWY
creatinine degradation II
-
-
PWY-4722
cremeomycin biosynthesis
-
-
PWY-8296
crepenynate biosynthesis
-
-
PWY-6013
crotonate fermentation (to acetate and cyclohexane carboxylate)
-
-
PWY-7401
crotonyl-CoA/ethylmalonyl-CoA/hydroxybutyryl-CoA cycle (engineered)
-
-
PWY-7854
curacin A biosynthesis
-
-
PWY-8358
curcuminoid biosynthesis
cuticular wax biosynthesis
-
-
PWY-282
cutin biosynthesis
-
-
PWY-321
Cutin, suberine and wax biosynthesis
-
-
cyanate degradation
cyanide detoxification II
-
-
PWY-7142
Cyanoamino acid metabolism
-
-
cyanophycin metabolism
-
-
PWY-7052
cyclic electron flow
-
-
PWY-8270
cyclopropane fatty acid (CFA) biosynthesis
-
-
PWY0-541
cylindrospermopsin biosynthesis
-
-
PWY-8045
Cysteine and methionine metabolism
-
-
cysteine metabolism
-
-
cytidylyl molybdenum cofactor sulfurylation
-
-
PWY-8165
cytochrome c biogenesis (system I type)
-
-
PWY-8147
cytochrome c biogenesis (system II type)
-
-
PWY-8146
cytochrome c biogenesis (system III type)
-
-
PWY-8145
cytokinin-O-glucosides biosynthesis
-
-
PWY-2902
cytosolic NADPH production (yeast)
-
-
PWY-7268
D-Amino acid metabolism
-
-
D-arabinitol degradation I
-
-
DARABITOLUTIL-PWY
D-arabinose degradation III
-
-
PWY-5519
D-arabinose degradation IV
-
-
PWY-8331
D-arabinose degradation V
-
-
PWY-8334
D-cycloserine biosynthesis
-
-
PWY-7274
D-galactosamine and N-acetyl-D-galactosamine degradation
-
-
PWY-7395
D-galactose degradation I (Leloir pathway)
-
-
PWY-6317
D-galactose degradation II
-
-
GALDEG-PWY
D-galactose degradation IV
-
-
PWY-6693
D-galactose detoxification
-
-
PWY-3821
D-galacturonate degradation II
-
-
PWY-6486
D-galacturonate degradation III
-
-
PWY-8391
D-gluconate degradation
-
-
GLUCONSUPER-PWY
D-glucuronate degradation I
-
-
PWY-5525
D-glucuronate degradation II
-
-
PWY-6501
D-glucuronate degradation III
-
-
PWY-8390
D-lactate to cytochrome bo oxidase electron transfer
-
-
PWY0-1565
d-mannose degradation
-
-
D-mannose degradation I
-
-
MANNCAT-PWY
D-mannose degradation II
-
-
PWY3O-1743
D-myo-inositol (1,3,4)-trisphosphate biosynthesis
-
-
PWY-6364
D-myo-inositol (1,4,5)-trisphosphate biosynthesis
-
-
PWY-6351
D-myo-inositol (1,4,5)-trisphosphate degradation
-
-
PWY-6363
D-myo-inositol (1,4,5,6)-tetrakisphosphate biosynthesis
-
-
PWY-6366
D-myo-inositol (3,4,5,6)-tetrakisphosphate biosynthesis
-
-
PWY-6365
D-myo-inositol-5-phosphate metabolism
-
-
PWY-6367
D-phenylglycine degradation
-
-
PWY-8161
D-sorbitol biosynthesis I
-
-
PWY-5054
D-sorbitol degradation I
-
-
PWY-4101
D-tagatose degradation
-
-
PWY-8324
d-xylose degradation
-
-
D-xylose degradation I
-
-
XYLCAT-PWY
D-xylose degradation IV
-
-
PWY-7294
D-xylose degradation to ethylene glycol (engineered)
-
-
PWY-7178
daidzein conjugates interconversion
-
-
PWY-2343
daidzin and daidzein degradation
-
-
PWY-6996
deacetylcephalosporin C biosynthesis
-
-
PWY-5631
degradation of aromatic, nitrogen containing compounds
-
-
degradation of hexoses
-
-
degradation of pentoses
-
-
degradation of sugar acids
-
-
degradation of sugar alcohols
-
-
dehydro-D-arabinono-1,4-lactone biosynthesis
-
-
PWY3O-6
denitrification
-
-
dermatan sulfate biosynthesis
-
-
PWY-6568
dermatan sulfate degradation I (bacterial)
-
-
PWY-7646
desferrioxamine B biosynthesis
-
-
PWY-6376
desferrioxamine E biosynthesis
-
-
PWY-6375
detoxification of reactive carbonyls in chloroplasts
-
-
PWY-6786
di-homo-gamma-linolenate metabolites biosynthesis
-
-
PWY-8396
di-myo-inositol phosphate biosynthesis
-
-
PWY-6664
di-trans,poly-cis-undecaprenyl phosphate biosynthesis
-
-
PWY-5785
diacylglycerol and triacylglycerol biosynthesis
-
-
TRIGLSYN-PWY
diacylglycerol biosynthesis (PUFA enrichment in oilseed)
-
-
PWY-6804
diethylphosphate degradation
-
-
PWY-5491
digitoxigenin biosynthesis
-
-
PWY-6032
DIMBOA-glucoside biosynthesis
-
-
PWY-6950
dimethyl sulfide biosynthesis from methionine
-
-
PWY-7793
dimethyl sulfide degradation I
-
-
PWY-6047
dimethylsulfoniopropanoate biosynthesis I (Wollastonia)
-
-
PWY-6054
dimethylsulfoniopropanoate biosynthesis II (Spartina)
-
-
PWY-6055
dimethylsulfoniopropanoate biosynthesis III (algae and phytoplankton)
-
-
PWY-6053
dimethylsulfoniopropanoate degradation I (cleavage)
-
-
PWY-6046
dimorphecolate biosynthesis
-
-
PWY-5368
dimycocerosyl phthiocerol biosynthesis
-
-
PWY-7744
dimycocerosyl triglycosyl phenolphthiocerol biosynthesis
-
-
PWY-7743
Dioxin degradation
-
-
diphenyl ethers degradation
-
-
PWY-7747
diphthamide biosynthesis I (archaea)
-
-
PWY-6482
diphthamide biosynthesis II (eukaryotes)
-
-
PWY-7546
dipicolinate biosynthesis
-
-
PWY-8088
dissimilatory sulfate reduction I (to hydrogen sufide))
-
-
DISSULFRED-PWY
Diterpenoid biosynthesis
-
-
divinyl ether biosynthesis I
-
-
PWY-5406
divinyl ether biosynthesis II
-
-
PWY-5409
docosahexaenoate biosynthesis I (lower eukaryotes)
-
-
PWY-7053
docosahexaenoate biosynthesis III (6-desaturase, mammals)
-
-
PWY-7606
docosahexaenoate biosynthesis IV (4-desaturase, mammals)
-
-
PWY-7727
docosahexaenoate metabolites biosynthesis
-
-
PWY-8400
dolichol and dolichyl phosphate biosynthesis
dolichyl-diphosphooligosaccharide biosynthesis
-
-
dopamine degradation
-
-
PWY6666-2
drosopterin and aurodrosopterin biosynthesis
-
-
PWY-7442
Drug metabolism - cytochrome P450
-
-
Drug metabolism - other enzymes
-
-
dTDP-3-acetamido-3,6-dideoxy-alpha-D-glucose biosynthesis
-
-
PWY-7318
dTDP-3-acetamido-alpha-D-fucose biosynthesis
-
-
PWY-6953
dTDP-4-O-demethyl-beta-L-noviose biosynthesis
-
-
PWY-7301
dTDP-6-deoxy-alpha-D-allose biosynthesis
-
-
PWY-7413
dTDP-alpha-D-forosamine biosynthesis
-
-
PWY-6808
dTDP-alpha-D-mycaminose biosynthesis
-
-
PWY-7414
dTDP-alpha-D-olivose, dTDP-alpha-D-oliose and dTDP-alpha-D-mycarose biosynthesis
-
-
PWY-6973
dTDP-alpha-D-ravidosamine and dTDP-4-acetyl-alpha-D-ravidosamine biosynthesis
-
-
PWY-7688
dTDP-beta-D-fucofuranose biosynthesis
-
-
PWY-7312
dTDP-beta-L-4-epi-vancosamine biosynthesis
-
-
PWY-7440
dTDP-beta-L-digitoxose biosynthesis
-
-
PWY-7657
dTDP-beta-L-megosamine biosynthesis
-
-
PWY-7104
dTDP-beta-L-mycarose biosynthesis
-
-
PWY-6976
dTDP-beta-L-olivose biosynthesis
-
-
PWY-6974
dTDP-beta-L-rhamnose biosynthesis
-
-
DTDPRHAMSYN-PWY
dTDP-D-desosamine biosynthesis
-
-
PWY-6942
dTDP-L-daunosamine biosynthesis
-
-
PWY-7814
dTDP-N-acetylthomosamine biosynthesis
-
-
PWY-7315
dTDP-N-acetylviosamine biosynthesis
-
-
PWY-7316
dTDP-sibirosamine biosynthesis
-
-
PWY-8380
dTDPLrhamnose biosynthesis
-
-
dTMP de novo biosynthesis (mitochondrial)
-
-
PWY66-385
dZTP biosynthesis
-
-
PWY-8289
ecdysone and 20-hydroxyecdysone biosynthesis
-
-
PWY-7300
echinatin biosynthesis
-
-
PWY-6325
ectoine biosynthesis
-
-
P101-PWY
enterobactin biosynthesis
Entner Doudoroff pathway
-
-
Entner-Doudoroff pathway I
-
-
PWY-8004
Entner-Doudoroff pathway II (non-phosphorylative)
-
-
NPGLUCAT-PWY
Entner-Doudoroff pathway III (semi-phosphorylative)
-
-
PWY-2221
ephedrine biosynthesis
-
-
PWY-5883
epiberberine biosynthesis
-
-
PWY-8031
epoxysqualene biosynthesis
-
-
PWY-5670
ergosterol biosynthesis I
-
-
PWY-6075
ergosterol biosynthesis II
-
-
PWY-7154
ergothioneine biosynthesis I (bacteria)
-
-
PWY-7255
erythritol biosynthesis I
-
-
PWY-8372
erythritol biosynthesis II
-
-
PWY-8373
erythro-tetrahydrobiopterin biosynthesis I
-
-
PWY-5663
erythromycin D biosynthesis
-
-
PWY-7106
Escherichia coli serotype O:127 O antigen biosynthesis
-
-
PWY-8231
Escherichia coli serotype O:1B/Salmonella enterica serotype O:42 O antigen biosynthesis
-
-
PWY-8237
Escherichia coli serotype O:85/Salmonella enterica serotype O:17 O antigen biosynthesis
-
-
PWY-8207
Escherichia coli serotype O:86 O antigen biosynthesis
-
-
PWY-7290
Escherichia coli serotype O:9 O antigen biosynthesis
-
-
PWY-8250
Escherichia coli serotype O:9a O antigen biosynthesis
-
-
PWY-7905
estradiol biosynthesis I (via estrone)
-
-
PWY66-380
ethanol degradation I
-
-
ETOH-ACETYLCOA-ANA-PWY
ethanol degradation II
-
-
PWY66-21
ethanol degradation III
-
-
PWY66-161
ethanol degradation IV
-
-
PWY66-162
ethanol fermentation
-
-
ethanolamine utilization
-
-
PWY0-1477
ethene biosynthesis I (plants)
-
-
ETHYL-PWY
ethene biosynthesis II (microbes)
-
-
PWY-6853
ethene biosynthesis III (microbes)
-
-
PWY-6854
ethene biosynthesis IV (engineered)
-
-
PWY-7126
ethene biosynthesis V (engineered)
-
-
PWY-7124
Ether lipid metabolism
-
-
ethiin metabolism
-
-
PWY-5708
Ethylbenzene degradation
-
-
ethylbenzene degradation (anaerobic)
-
-
PWY-481
ethylmalonyl-CoA pathway
eumelanin biosynthesis
-
-
PWY-6498
even iso-branched-chain fatty acid biosynthesis
-
-
PWY-8175
extended VTC2 cycle
-
-
PWY4FS-13
factor 420 biosynthesis II (mycobacteria)
-
-
PWY-5198
farnesylcysteine salvage pathway
-
-
PWY-6577
fatty acid alpha-oxidation I (plants)
-
-
PWY-2501
fatty acid beta-oxidation I (generic)
-
-
FAO-PWY
fatty acid beta-oxidation II (plant peroxisome)
-
-
PWY-5136
fatty acid beta-oxidation III (unsaturated, odd number)
-
-
PWY-5137
fatty acid beta-oxidation IV (unsaturated, even number)
-
-
PWY-5138
fatty acid beta-oxidation V (unsaturated, odd number, di-isomerase-dependent)
-
-
PWY-6837
fatty acid beta-oxidation VI (mammalian peroxisome)
-
-
PWY66-391
fatty acid beta-oxidation VII (yeast peroxisome)
-
-
PWY-7288
Fatty acid biosynthesis
-
-
fatty acid biosynthesis initiation (mitochondria)
-
-
PWY66-429
fatty acid biosynthesis initiation (plant mitochondria)
-
-
PWY-6799
fatty acid biosynthesis initiation (type I)
-
-
PWY-5966-1
fatty acid biosynthesis initiation (type II)
-
-
PWY-4381
Fatty acid degradation
-
-
Fatty acid elongation
-
-
fatty acid elongation -- saturated
-
-
FASYN-ELONG-PWY
fatty acid salvage
-
-
PWY-7094
Fe(II) oxidation
-
-
PWY-6692
felinine and 3-methyl-3-sulfanylbutan-1-ol biosynthesis
-
-
PWY-8001
FeMo cofactor biosynthesis
-
-
PWY-7710
fenchol biosynthesis II
-
-
PWY-6445
ferrichrome A biosynthesis
-
-
PWY-7571
firefly bioluminescence
-
-
PWY-7913
flavin biosynthesis
-
-
flavin biosynthesis I (bacteria and plants)
-
-
RIBOSYN2-PWY
flavin biosynthesis II (archaea)
-
-
PWY-6167
flavin biosynthesis III (fungi)
-
-
PWY-6168
flavin salvage
-
-
PWY66-366
Flavone and flavonol biosynthesis
-
-
flavonoid biosynthesis
-
-
PWY1F-FLAVSYN
Flavonoid biosynthesis
-
-
flavonoid biosynthesis
-
-
flavonoid biosynthesis (in equisetum)
-
-
PWY-6787
flavonoid di-C-glucosylation
-
-
PWY-7897
flexixanthin biosynthesis
-
-
PWY-7947
fluoroacetate and fluorothreonine biosynthesis
-
-
PWY-6644
fluoroacetate degradation
-
-
PWY-6646
Fluorobenzoate degradation
-
-
Folate biosynthesis
-
-
folate polyglutamylation
folate transformations I
-
-
PWY-2201
folate transformations II (plants)
-
-
PWY-3841
folate transformations III (E. coli)
-
-
1CMET2-PWY
formaldehyde assimilation I (serine pathway)
-
-
PWY-1622
formaldehyde assimilation II (assimilatory RuMP Cycle)
-
-
PWY-1861
formaldehyde assimilation III (dihydroxyacetone cycle)
-
-
P185-PWY
formaldehyde oxidation
-
-
formaldehyde oxidation I
-
-
RUMP-PWY
formaldehyde oxidation II (glutathione-dependent)
-
-
PWY-1801
formaldehyde oxidation IV (thiol-independent)
-
-
FORMASS-PWY
formaldehyde oxidation VII (THF pathway)
-
-
PWY-7909
formate assimilation into 5,10-methylenetetrahydrofolate
-
-
PWY-1722
formate oxidation to CO2
-
-
PWY-1881
formate to dimethyl sulfoxide electron transfer
-
-
PWY0-1356
formate to nitrite electron transfer
-
-
PWY0-1585
formononetin conjugates interconversion
-
-
PWY-2904
fructan biosynthesis
-
-
PWY-822
fructan degradation
-
-
PWY-862
fructose 2,6-bisphosphate biosynthesis
-
-
PWY66-423
Fructose and mannose metabolism
-
-
fructose degradation
-
-
PWY0-1314
fusicoccin A biosynthesis
-
-
PWY-6659
GABA shunt I
-
-
GLUDEG-I-PWY
GABA shunt II
-
-
PWY-8346
gala-series glycosphingolipids biosynthesis
-
-
PWY-7840
galactitol degradation
-
-
GALACTITOLCAT-PWY
Galactose metabolism
-
-
gallate biosynthesis
-
-
PWY-6707
gallate degradation III (anaerobic)
-
-
P3-PWY
gamma-butyrobetaine degradation II
-
-
PWY-3621
gamma-glutamyl cycle
-
-
PWY-4041
gamma-hexachlorocyclohexane degradation
-
-
GAMMAHEXCHLORDEG-PWY
gamma-linolenate biosynthesis II (animals)
-
-
PWY-6000
ganglio-series glycosphingolipids biosynthesis
-
-
PWY-7836
GDP-6-deoxy-D-talose biosynthesis
-
-
PWY-5738
GDP-alpha-D-glucose biosynthesis
-
-
PWY-5661
GDP-D-perosamine biosynthesis
-
-
PWY-5739
GDP-D-rhamnose biosynthesis
-
-
GDPRHAMSYN-PWY
GDP-L-colitose biosynthesis
-
-
PWY-5740
GDP-L-fucose biosynthesis I (from GDP-D-mannose)
-
-
PWY-66
GDP-L-fucose biosynthesis II (from L-fucose)
-
-
PWY-6
GDP-L-galactose biosynthesis
-
-
PWY-5115
GDP-mannose biosynthesis
-
-
PWY-5659
GDP-mycosamine biosynthesis
-
-
PWY-7573
GDP-N-acetyl-alpha-D-perosamine biosynthesis
-
-
PWY-8225
GDP-N-formyl-alpha-D-perosamine biosynthesis
-
-
PWY2B4Q-2
gellan degradation
-
-
PWY-6827
genistein conjugates interconversion
-
-
PWY-2345
gentisate degradation I
-
-
PWY-6223
Geraniol degradation
-
-
geranyl diphosphate biosynthesis
-
-
PWY-5122
geranylgeranyl diphosphate biosynthesis
-
-
PWY-5120
ginkgotoxin biosynthesis
-
-
PWY-8077
ginsenoside metabolism
-
-
ginsenosides biosynthesis
-
-
PWY-5672
gliotoxin biosynthesis
-
-
PWY-7533
globo-series glycosphingolipids biosynthesis
-
-
PWY-7838
glucocorticoid biosynthesis
-
-
PWY66-381
gluconeogenesis
-
-
gluconeogenesis I
-
-
GLUCONEO-PWY
gluconeogenesis II (Methanobacterium thermoautotrophicum)
-
-
PWY-6142
gluconeogenesis III
-
-
PWY66-399
glucose and glucose-1-phosphate degradation
-
-
GLUCOSE1PMETAB-PWY
glucose degradation (oxidative)
-
-
DHGLUCONATE-PYR-CAT-PWY
glucosinolate activation
-
-
PWY-5267
Glucosinolate biosynthesis
-
-
glucosinolate biosynthesis from dihomomethionine
-
-
PWYQT-4471
glucosinolate biosynthesis from hexahomomethionine
-
-
PWYQT-4475
glucosinolate biosynthesis from homomethionine
-
-
PWY-1187
glucosinolate biosynthesis from pentahomomethionine
-
-
PWYQT-4474
glucosinolate biosynthesis from phenylalanine
-
-
PWY-2821
glucosinolate biosynthesis from tetrahomomethionine
-
-
PWYQT-4473
glucosinolate biosynthesis from trihomomethionine
-
-
PWYQT-4472
glucosinolate biosynthesis from tryptophan
-
-
PWY-601
glucosinolate biosynthesis from tyrosine
-
-
PWY-7901
glucosylglycerol biosynthesis
-
-
PWY-7902
glutamate and glutamine metabolism
-
-
glutamate removal from folates
-
-
PWY-2161B
glutaminyl-tRNAgln biosynthesis via transamidation
-
-
PWY-5921
glutaryl-CoA degradation
-
-
PWY-5177
glutathione amide metabolism
-
-
PWY-4181
glutathione biosynthesis
-
-
GLUTATHIONESYN-PWY
glutathione degradation (DUG pathway)
-
-
PWY-7559
Glutathione metabolism
-
-
glutathione metabolism
-
-
glutathione-mediated detoxification
-
-
glutathione-mediated detoxification I
-
-
PWY-4061
glutathione-mediated detoxification II
-
-
PWY-6842
glutathione-peroxide redox reactions
-
-
PWY-4081
glutathionylspermidine biosynthesis
-
-
PWY-4121
glycerol degradation I
-
-
PWY-4261
glycerol degradation II
-
-
PWY-6131
glycerol degradation to butanol
-
-
PWY-7003
glycerol degradation V
-
-
GLYCEROLMETAB-PWY
glycerol-3-phosphate shuttle
-
-
PWY-6118
glycerol-3-phosphate to cytochrome bo oxidase electron transfer
-
-
PWY0-1561
glycerol-3-phosphate to fumarate electron transfer
-
-
PWY0-1582
glycerol-3-phosphate to hydrogen peroxide electron transport
-
-
PWY0-1591
Glycerolipid metabolism
-
-
glycerophosphodiester degradation
-
-
PWY-6952
Glycerophospholipid metabolism
-
-
glycine betaine biosynthesis
-
-
glycine betaine biosynthesis I (Gram-negative bacteria)
-
-
BETSYN-PWY
glycine betaine biosynthesis IV (from glycine)
-
-
P541-PWY
glycine betaine biosynthesis V (from glycine)
-
-
PWY-6004
glycine betaine degradation I
-
-
PWY-3661
glycine betaine degradation II (mammalian)
-
-
PWY-3661-1
glycine betaine degradation III
-
-
PWY-8325
glycine biosynthesis I
-
-
GLYSYN-PWY
glycine biosynthesis II
-
-
GLYCINE-SYN2-PWY
glycine biosynthesis III
-
-
GLYSYN-ALA-PWY
glycine biosynthesis IV
-
-
GLYSYN-THR-PWY
glycine cleavage
-
-
GLYCLEAV-PWY
glycine degradation (reductive Stickland reaction)
-
-
PWY-8015
glycine metabolism
-
-
Glycine, serine and threonine metabolism
-
-
glycogen biosynthesis
-
-
glycogen biosynthesis I (from ADP-D-Glucose)
-
-
GLYCOGENSYNTH-PWY
glycogen biosynthesis II (from UDP-D-Glucose)
-
-
PWY-5067
glycogen biosynthesis III (from alpha-maltose 1-phosphate)
-
-
PWY-7900
glycogen degradation I
-
-
GLYCOCAT-PWY
glycogen degradation II
-
-
PWY-5941
glycogen degradation III (via anhydrofructose)
-
-
PWY-7662
glycogen metabolism
-
-
glycolate and glyoxylate degradation
-
-
glycolate and glyoxylate degradation II
-
-
GLYOXDEG-PWY
glycolipid desaturation
-
-
PWY-782
glycolysis
-
-
Glycolysis / Gluconeogenesis
-
-
glycolysis I (from glucose 6-phosphate)
-
-
GLYCOLYSIS
glycolysis II (from fructose 6-phosphate)
-
-
PWY-5484
glycolysis III (from glucose)
-
-
ANAGLYCOLYSIS-PWY
glycolysis IV
-
-
PWY-1042
glycolysis V (Pyrococcus)
-
-
P341-PWY
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate
-
-
Glycosaminoglycan biosynthesis - heparan sulfate / heparin
-
-
Glycosaminoglycan biosynthesis - keratan sulfate
-
-
Glycosaminoglycan degradation
-
-
glycosaminoglycan-protein linkage region biosynthesis
-
-
PWY-6557
Glycosphingolipid biosynthesis - ganglio series
-
-
Glycosphingolipid biosynthesis - globo and isoglobo series
-
-
Glycosphingolipid biosynthesis - lacto and neolacto series
-
-
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis
-
-
Glyoxylate and dicarboxylate metabolism
-
-
glyoxylate assimilation
-
-
PWY-5744
glyoxylate cycle
-
-
GLYOXYLATE-BYPASS
glyphosate degradation III
-
-
PWY-7807
gondoate biosynthesis (anaerobic)
-
-
PWY-7663
gossypol biosynthesis
-
-
PWY-5773
grixazone biosynthesis
-
-
PWY-7153
guadinomine B biosynthesis
-
-
PWY-7693
guaiacol biosynthesis
-
-
PWY18C3-23
guanine and guanosine salvage I
-
-
PWY-6620
guanine and guanosine salvage II
-
-
PWY-6599
guanine and guanosine salvage III
-
-
PWY-6618
guanosine deoxyribonucleotides de novo biosynthesis I
-
-
PWY-7226
guanosine deoxyribonucleotides de novo biosynthesis II
-
-
PWY-7222
guanosine nucleotides degradation I
-
-
PWY-6607
guanosine nucleotides degradation II
-
-
PWY-6606
guanosine nucleotides degradation III
-
-
PWY-6608
guanosine ribonucleotides de novo biosynthesis
-
-
PWY-7221
H. pylori 26695 O-antigen biosynthesis
-
-
PWY2DNV-5
heme a biosynthesis
-
-
PWY-7856
heme b biosynthesis I (aerobic)
-
-
HEME-BIOSYNTHESIS-II
heme b biosynthesis II (oxygen-independent)
-
-
HEMESYN2-PWY
heme b biosynthesis IV (Gram-positive bacteria)
-
-
PWY-7766
heme b biosynthesis V (aerobic)
-
-
HEME-BIOSYNTHESIS-II-1
heme degradation I
-
-
PWY-5874
heme metabolism
-
-
hemoglobin degradation
-
-
PWY-6423
heparan sulfate biosynthesis
-
-
PWY-6558
heparan sulfate degradation
-
-
PWY-7651
heparin degradation
-
-
PWY-7644
heptadecane biosynthesis
-
-
PWY-6622
heterolactic fermentation
-
-
P122-PWY
histamine biosynthesis
-
-
PWY-6173
histamine degradation
-
-
PWY-6181
Histidine metabolism
-
-
histidine metabolism
-
-
homocarnosine biosynthesis
-
-
PWY66-421
homocysteine and cysteine interconversion
-
-
PWY-801
homoglutathione biosynthesis
-
-
PWY-6840
homospermidine biosynthesis I
-
-
PWY-5907
homospermidine biosynthesis II
-
-
PWY-8149
hordatine biosynthesis
-
-
PWY-6448
hyaluronan degradation
-
-
PWY-7645
hydrogen oxidation I (aerobic)
-
-
P283-PWY
hydrogen oxidation II (aerobic, NAD)
-
-
PWY-5382
hydrogen production
-
-
hydrogen production II
-
-
PWY-6758
hydrogen production III
-
-
PWY-6759
hydrogen production VI
-
-
PWY-6780
hydrogen production VIII
-
-
PWY-6785
hydrogen sulfide biosynthesis II (mammalian)
-
-
PWY66-426
hydrogen to dimethyl sulfoxide electron transfer
-
-
PWY0-1577
hydrogen to fumarate electron transfer
-
-
PWY0-1576
hydroxycinnamic acid serotonin amides biosynthesis
-
-
PWY-5473
hydroxycinnamic acid tyramine amides biosynthesis
-
-
PWY-5474
hydroxylated fatty acid biosynthesis (plants)
-
-
PWY-6433
hydroxymethylpyrimidine salvage
-
-
PWY-6910
hyperxanthone E biosynthesis
-
-
PWY-7169
hypoglycin biosynthesis
-
-
PWY-5826
hypotaurine degradation
-
-
PWY-7387
hypusine biosynthesis
-
-
PWY-5905
i antigen and I antigen biosynthesis
-
-
PWY-7837
IAA biosynthesis
-
-
icosapentaenoate biosynthesis I (lower eukaryotes)
-
-
PWY-6958
icosapentaenoate biosynthesis II (6-desaturase, mammals)
-
-
PWY-7049
icosapentaenoate biosynthesis III (8-desaturase, mammals)
-
-
PWY-7724
icosapentaenoate biosynthesis V (8-desaturase, lower eukaryotes)
-
-
PWY-7602
icosapentaenoate biosynthesis VI (fungi)
-
-
PWY-6940
icosapentaenoate metabolites biosynthesis
-
-
PWY-8399
incomplete reductive TCA cycle
-
-
P42-PWY
Indole alkaloid biosynthesis
-
-
indole degradation to anthranil and anthranilate
-
-
PWY-7430
indole glucosinolate activation (herbivore attack)
-
-
PWYQT-4476
indole glucosinolate activation (intact plant cell)
-
-
PWYQT-4477
indole-3-acetate biosynthesis II
-
-
PWY-581
indole-3-acetate biosynthesis III (bacteria)
-
-
PWY-3161
indole-3-acetate biosynthesis IV (bacteria)
-
-
PWY-5025
indole-3-acetate biosynthesis V (bacteria and fungi)
-
-
PWY-5026
indole-3-acetate biosynthesis VI (bacteria)
-
-
TRPIAACAT-PWY
inosine 5'-phosphate degradation
-
-
PWY-5695
inosine-5'-phosphate biosynthesis I
-
-
PWY-6123
inosine-5'-phosphate biosynthesis II
-
-
PWY-6124
inosine-5'-phosphate biosynthesis III
-
-
PWY-7234
inositol diphosphates biosynthesis
-
-
PWY-6369
Inositol phosphate metabolism
-
-
Insect hormone biosynthesis
-
-
inulin degradation
-
-
PWY-8314
ipsdienol biosynthesis
-
-
PWY-7410
iron reduction and absorption
-
-
PWY-5934
Isoflavonoid biosynthesis
-
-
isoflavonoid biosynthesis I
-
-
PWY-2002
isoflavonoid biosynthesis II
-
-
PWY-2083
isoleucine metabolism
-
-
isoprene biosynthesis II (engineered)
-
-
PWY-7391
isoprenoid biosynthesis
-
-
isopropanol biosynthesis (engineered)
-
-
PWY-6876
Isoquinoline alkaloid biosynthesis
-
-
itaconate biosynthesis I
-
-
PWY-5750
itaconate degradation
-
-
PWY-5749
jadomycin biosynthesis
-
-
PWY-6679
jasmonic acid biosynthesis
-
-
PWY-735
juniperonate biosynthesis
-
-
PWY-7619
justicidin B biosynthesis
-
-
PWY-6824
juvenile hormone III biosynthesis I
-
-
PWY-6575
juvenile hormone III biosynthesis II
-
-
PWY-6650
kappa-carrageenan degradation
-
-
PWY-6821
Kdo transfer to lipid IVA (Brucella)
-
-
PWY2B4Q-6
Kdo transfer to lipid IVA (E. coli)
-
-
KDOSYN-PWY
Kdo transfer to lipid IVA (generic)
-
-
PWY-8284
Kdo transfer to lipid IVA (H. pylori)
-
-
PWY2DNV-1
Kdo transfer to lipid IVA (Haemophilus)
-
-
PWY-7675
Kdo transfer to lipid IVA (P. gingivalis)
-
-
PWY-8246
Kdo transfer to lipid IVA (P. putida)
-
-
PWY-8074
Kdo transfer to lipid IVA (Vibrio cholerae serogroup O1 El Tor)
-
-
PWY-8284-1
Kdo-lipid A biosynthesis (Vibrio cholerae serogroup O1 El Tor)
-
-
PWY-8378
Kdo8N transfer to lipid IVA
-
-
PWY-7676
ketogenesis
-
-
PWY66-367
ketogluconate metabolism
ketolysis
-
-
PWY66-368
L-alanine biosynthesis I
-
-
ALANINE-VALINESYN-PWY
L-alanine biosynthesis II
-
-
ALANINE-SYN2-PWY
L-alanine biosynthesis III
-
-
PWY0-1021
L-alanine degradation I
-
-
ALADEG-PWY
L-alanine degradation II (to D-lactate)
-
-
ALACAT2-PWY
L-alanine degradation III
-
-
ALANINE-DEG3-PWY
L-alanine degradation IV
-
-
PWY1-2
L-alanine degradation V (oxidative Stickland reaction)
-
-
PWY-8189
L-alanine degradation VI (reductive Stickland reaction)
-
-
PWY-8188
L-arabinose degradation II
-
-
PWY-5515
L-arabinose degradation III
-
-
PWY-5517
L-arabinose degradation IV
-
-
PWY-7295
L-arabinose degradation V
-
-
PWY-8329
L-arginine biosynthesis I (via L-ornithine)
-
-
ARGSYN-PWY
L-arginine biosynthesis II (acetyl cycle)
-
-
ARGSYNBSUB-PWY
L-arginine biosynthesis III (via N-acetyl-L-citrulline)
-
-
PWY-5154
L-arginine biosynthesis IV (archaea)
-
-
PWY-7400
L-arginine degradation I (arginase pathway)
-
-
ARGASEDEG-PWY
L-arginine degradation II (AST pathway)
-
-
AST-PWY
L-arginine degradation III (arginine decarboxylase/agmatinase pathway)
-
-
PWY0-823
L-arginine degradation IV (arginine decarboxylase/agmatine deiminase pathway)
-
-
ARGDEG-III-PWY
L-arginine degradation IX (arginine:pyruvate transaminase pathway)
-
-
PWY-5742
L-arginine degradation V (arginine deiminase pathway)
-
-
ARGDEGRAD-PWY
L-arginine degradation VI (arginase 2 pathway)
-
-
ARG-PRO-PWY
L-arginine degradation VII (arginase 3 pathway)
-
-
ARG-GLU-PWY
L-arginine degradation VIII (arginine oxidase pathway)
-
-
ARGDEG-IV-PWY
L-arginine degradation X (arginine monooxygenase pathway)
-
-
ARGDEG-V-PWY
L-arginine degradation XI
-
-
PWY-5024
L-arginine degradation XII
-
-
PWY-7523
L-arginine degradation XIII (reductive Stickland reaction)
-
-
PWY-8187
L-arginine degradation XIV (oxidative Stickland reaction)
-
-
PWY-6344
L-ascorbate biosynthesis I (plants, L-galactose pathway)
-
-
PWY-882
L-ascorbate biosynthesis II (plants, L-gulose pathway)
-
-
PWY4FS-11
L-ascorbate biosynthesis IV (animals, D-glucuronate pathway)
-
-
PWY3DJ-35471
L-ascorbate biosynthesis VI (plants, myo-inositol pathway)
-
-
PWY-8142
L-ascorbate biosynthesis VIII (engineered pathway)
-
-
PWY-7165
L-ascorbate degradation I (bacterial, anaerobic)
-
-
PWY0-301
L-ascorbate degradation II (bacterial, aerobic)
-
-
PWY-6961
L-ascorbate degradation III
-
-
PWY-6960
L-asparagine biosynthesis I
-
-
ASPARAGINE-BIOSYNTHESIS
L-asparagine biosynthesis II
-
-
ASPARAGINESYN-PWY
L-asparagine biosynthesis III (tRNA-dependent)
-
-
PWY490-4
L-asparagine degradation I
-
-
ASPARAGINE-DEG1-PWY
L-asparagine degradation II
-
-
PWY-4002
L-asparagine degradation III (mammalian)
-
-
ASPARAGINE-DEG1-PWY-1
L-aspartate biosynthesis
-
-
ASPARTATESYN-PWY
L-aspartate degradation I
-
-
ASPARTATE-DEG1-PWY
L-aspartate degradation II (aerobic)
-
-
PWY-8291
L-aspartate degradation III (anaerobic)
-
-
PWY-8294
L-carnitine biosynthesis
-
-
PWY-6100
L-carnitine degradation II
-
-
PWY-3641
L-citrulline biosynthesis
-
-
CITRULBIO-PWY
L-citrulline degradation
-
-
CITRULLINE-DEG-PWY
L-cysteine biosynthesis I
-
-
CYSTSYN-PWY
L-cysteine biosynthesis II (tRNA-dependent)
-
-
PWY-6308
L-cysteine biosynthesis III (from L-homocysteine)
-
-
HOMOCYSDEGR-PWY
L-cysteine biosynthesis IX (Trichomonas vaginalis)
-
-
PWY-8010
L-cysteine biosynthesis VI (reverse transsulfuration)
-
-
PWY-I9
L-cysteine biosynthesis VII (from S-sulfo-L-cysteine)
-
-
PWY-7870
L-cysteine biosynthesis VIII (Thermococcus kodakarensis)
-
-
PWY-8009
L-cysteine degradation I
-
-
CYSTEINE-DEG-PWY
L-cysteine degradation III
-
-
PWY-5329
L-dopa and L-dopachrome biosynthesis
-
-
PWY-6481
L-dopa degradation I (mammalian)
-
-
PWY-6334
L-dopa degradation II (bacterial)
-
-
PWY-8110
L-fucose degradation I
-
-
FUCCAT-PWY
L-fucose degradation II
-
-
PWY-8318
L-glutamate biosynthesis I
-
-
GLUTSYN-PWY
L-glutamate biosynthesis II
-
-
GLUTAMATE-SYN2-PWY
L-glutamate biosynthesis III
-
-
GLUTSYNIII-PWY
L-glutamate biosynthesis IV
-
-
GLUGLNSYN-PWY
L-glutamate degradation I
-
-
GLUTAMATE-DEG1-PWY
L-glutamate degradation II
-
-
GLUTDEG-PWY
L-glutamate degradation IX (via 4-aminobutanoate)
-
-
PWY0-1305
L-glutamate degradation V (via hydroxyglutarate)
-
-
P162-PWY
L-glutamate degradation VI (to pyruvate)
-
-
PWY-5087
L-glutamate degradation VII (to butanoate)
-
-
GLUDEG-II-PWY
L-glutamate degradation X
-
-
PWY-5766
L-glutamate degradation XI (reductive Stickland reaction)
-
-
PWY-8190
L-glutamine biosynthesis I
-
-
GLNSYN-PWY
L-glutamine degradation I
-
-
GLUTAMINDEG-PWY
L-glutamine degradation II
-
-
GLUTAMINEFUM-PWY
L-histidine biosynthesis
-
-
HISTSYN-PWY
L-histidine degradation I
-
-
HISDEG-PWY
L-histidine degradation II
-
-
PWY-5028
L-histidine degradation III
-
-
PWY-5030
L-histidine degradation IV
-
-
HISTDEG-PWY
L-histidine degradation V
-
-
PWY-5031
L-histidine degradation VI
-
-
HISHP-PWY
L-homocysteine biosynthesis
-
-
PWY-5344
L-homomethionine biosynthesis
-
-
PWY-1186
L-homophenylalanine biosynthesis
-
-
PWY-7275
L-homoserine biosynthesis
-
-
HOMOSERSYN-PWY
L-idonate degradation
-
-
IDNCAT-PWY
L-isoleucine biosynthesis I (from threonine)
-
-
ILEUSYN-PWY
L-isoleucine biosynthesis II
-
-
PWY-5101
L-isoleucine biosynthesis III
-
-
PWY-5103
L-isoleucine biosynthesis IV
-
-
PWY-5104
L-isoleucine biosynthesis V
-
-
PWY-5108
L-isoleucine degradation I
-
-
ILEUDEG-PWY
L-isoleucine degradation II
-
-
PWY-5078
L-isoleucine degradation III (oxidative Stickland reaction)
-
-
PWY-8184
L-lactaldehyde degradation
-
-
L-leucine biosynthesis
-
-
LEUSYN-PWY
L-leucine degradation I
-
-
LEU-DEG2-PWY
L-leucine degradation III
-
-
PWY-5076
L-leucine degradation IV (reductive Stickland reaction)
-
-
PWY-7767
L-leucine degradation V (oxidative Stickland reaction)
-
-
PWY-8185
L-lysine biosynthesis I
-
-
DAPLYSINESYN-PWY
L-lysine biosynthesis II
-
-
PWY-2941
L-lysine biosynthesis III
-
-
PWY-2942
L-lysine biosynthesis IV
-
-
LYSINE-AMINOAD-PWY
L-lysine biosynthesis V
-
-
PWY-3081
L-lysine biosynthesis VI
-
-
PWY-5097
L-lysine degradation I
-
-
PWY0-461
L-lysine degradation II (L-pipecolate pathway)
-
-
PWY66-425
L-lysine degradation IV
-
-
PWY-5280
L-lysine degradation V
-
-
PWY-5283
L-lysine degradation VII
-
-
PWY-5311
L-lysine degradation X
-
-
PWY-6328
L-lysine degradation XI
-
-
LYSINE-DEG1-PWY
L-lysine fermentation to acetate and butanoate
-
-
P163-PWY
L-malate degradation II
-
-
PWY-7686
L-methionine biosynthesis I
-
-
HOMOSER-METSYN-PWY
L-methionine biosynthesis II
-
-
PWY-702
L-methionine biosynthesis III
-
-
HSERMETANA-PWY
L-methionine biosynthesis IV
-
-
PWY-7977
L-methionine degradation I (to L-homocysteine)
-
-
METHIONINE-DEG1-PWY
L-methionine degradation III
-
-
PWY-5082
L-methionine salvage cycle II (plants)
-
-
PWY-7270
L-methionine salvage from L-homocysteine
-
-
ADENOSYLHOMOCYSCAT-PWY
L-Ndelta-acetylornithine biosynthesis
-
-
PWY-6922
L-nicotianamine biosynthesis
-
-
PWY-5957
L-ornithine biosynthesis I
-
-
GLUTORN-PWY
L-ornithine biosynthesis II
-
-
ARGININE-SYN4-PWY
L-ornithine degradation I (L-proline biosynthesis)
-
-
ORN-AMINOPENTANOATE-CAT-PWY
L-phenylalanine biosynthesis I
-
-
PHESYN
L-phenylalanine biosynthesis II
-
-
PWY-3462
L-phenylalanine biosynthesis III (cytosolic, plants)
-
-
PWY-7432
L-phenylalanine degradation I (aerobic)
-
-
PHENYLALANINE-DEG1-PWY
L-phenylalanine degradation II (anaerobic)
-
-
ANAPHENOXI-PWY
L-phenylalanine degradation III
-
-
PWY-5079
L-phenylalanine degradation IV (mammalian, via side chain)
-
-
PWY-6318
L-phenylalanine degradation V
-
-
PWY-7158
L-phenylalanine degradation VI (reductive Stickland reaction)
-
-
PWY-8014
L-proline biosynthesis I (from L-glutamate)
-
-
PROSYN-PWY
L-proline biosynthesis II (from arginine)
-
-
PWY-4981
L-proline biosynthesis III (from L-ornithine)
-
-
PWY-3341
L-proline biosynthesis IV
-
-
PWY-4281
L-proline degradation I
-
-
PROUT-PWY
L-proline degradation II (reductive Stickland reaction)
-
-
PWY-8186
L-pyrrolysine biosynthesis
-
-
PWY-6994
L-selenocysteine biosynthesis I (bacteria)
-
-
PWY0-901
L-selenocysteine biosynthesis II (archaea and eukaryotes)
-
-
PWY-6281
L-serine biosynthesis I
-
-
SERSYN-PWY
L-serine biosynthesis II
-
-
PWY-8011
L-threonine biosynthesis
-
-
HOMOSER-THRESYN-PWY
L-threonine degradation I
-
-
PWY-5437
L-threonine degradation II
-
-
THREONINE-DEG2-PWY
L-threonine degradation III (to methylglyoxal)
-
-
THRDLCTCAT-PWY
L-threonine degradation IV
-
-
PWY-5436
L-threonine degradation V
-
-
PWY66-428
L-tryptophan biosynthesis
-
-
TRPSYN-PWY
L-tryptophan degradation I (via anthranilate)
-
-
TRPCAT-PWY
L-tryptophan degradation IV (via indole-3-lactate)
-
-
TRPKYNCAT-PWY
L-tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde
-
-
PWY-5651
L-tryptophan degradation V (side chain pathway)
-
-
PWY-3162
L-tryptophan degradation VI (via tryptamine)
-
-
PWY-3181
L-tryptophan degradation VIII (to tryptophol)
-
-
PWY-5081
L-tryptophan degradation X (mammalian, via tryptamine)
-
-
PWY-6307
L-tryptophan degradation XI (mammalian, via kynurenine)
-
-
PWY-6309
L-tryptophan degradation XII (Geobacillus)
-
-
PWY-6505
L-tryptophan degradation XIII (reductive Stickland reaction)
-
-
PWY-8017
L-tyrosine biosynthesis I
-
-
TYRSYN
L-tyrosine biosynthesis II
-
-
PWY-3461
L-tyrosine biosynthesis III
-
-
PWY-6120
L-tyrosine biosynthesis IV
-
-
PWY-6134
L-tyrosine degradation I
-
-
TYRFUMCAT-PWY
L-tyrosine degradation II
-
-
PWY-5151
L-tyrosine degradation III
-
-
PWY3O-4108
L-tyrosine degradation IV (to 4-methylphenol)
-
-
PWY-7514
L-tyrosine degradation V (reductive Stickland reaction)
-
-
PWY-8016
L-valine biosynthesis
-
-
VALSYN-PWY
L-valine degradation I
-
-
VALDEG-PWY
L-valine degradation II
-
-
PWY-5057
L-valine degradation III (oxidative Stickland reaction)
-
-
PWY-8183
lacinilene C biosynthesis
-
-
PWY-5828
lactate fermentation
-
-
lactate fermentation to acetate, CO2 and hydrogen (Desulfovibrionales)
-
-
PWY-8377
lacto-series glycosphingolipids biosynthesis
-
-
PWY-7839
lactose and galactose degradation I
-
-
LACTOSECAT-PWY
lactose degradation III
-
-
BGALACT-PWY
laminaribiose degradation
-
-
PWY-6778
lanosterol biosynthesis
-
-
PWY-6132
leucine metabolism
-
-
leucodelphinidin biosynthesis
-
-
PWY-5152
leucopelargonidin and leucocyanidin biosynthesis
-
-
PWY1F-823
leukotriene biosynthesis
-
-
PWY66-375
Limonene and pinene degradation
-
-
limonene degradation IV (anaerobic)
-
-
PWY-8029
linalool biosynthesis I
-
-
PWY-7182
linamarin degradation
-
-
PWY-3121
linoleate biosynthesis I (plants)
-
-
PWY-5995
linoleate biosynthesis II (animals)
-
-
PWY-6001
linoleate metabolites biosynthesis
-
-
PWY-8395
Linoleic acid metabolism
-
-
linustatin bioactivation
-
-
PWY-7091
lipid A biosynthesis
-
-
lipid A-core biosynthesis (E. coli K-12)
-
-
LIPA-CORESYN-PWY
lipid A-core biosynthesis (Salmonella)
-
-
PWY1R65-1
lipid IVA biosynthesis (2,3-diamino-2,3-dideoxy-D-glucopyranose-containing)
-
-
PWY2B4Q-4
lipid IVA biosynthesis (E. coli)
-
-
NAGLIPASYN-PWY
lipid IVA biosynthesis (generic)
-
-
PWY-8283
lipid IVA biosynthesis (H. pylori)
-
-
PWYI-14
lipid IVA biosynthesis (P. gingivalis)
-
-
PWY-8245
lipid IVA biosynthesis (P. putida)
-
-
PWY-8073
lipid IVA biosynthesis (Vibrio cholerae serogroup O1 El Tor)
-
-
PWY2G6Z-2
lipid metabolism
-
-
Lipoarabinomannan (LAM) biosynthesis
-
-
lipoate biosynthesis
-
-
lipoate biosynthesis and incorporation I
-
-
PWY0-501
lipoate biosynthesis and incorporation II
-
-
PWY0-1275
lipoate biosynthesis and incorporation III (Bacillus)
-
-
PWY-6987
lipoate biosynthesis and incorporation IV (yeast)
-
-
PWY-7382
lipoate biosynthesis and incorporation V (mammals)
-
-
PWY0-501-1
Lipoic acid metabolism
-
-
Lipopolysaccharide biosynthesis
-
-
lipoprotein posttranslational modification
-
-
PWY-7884
lipoxin biosynthesis
-
-
PWY66-392
long chain fatty acid ester synthesis (engineered)
-
-
PWY-6873
long-chain fatty acid activation
-
-
PWY-5143
lotaustralin degradation
-
-
PWY-6002
lupanine biosynthesis
-
-
PWY-5468
lupulone and humulone biosynthesis
-
-
PWY-5132
luteolin biosynthesis
-
-
PWY-5060
luteolin triglucuronide degradation
-
-
PWY-7445
Lysine biosynthesis
-
-
Lysine degradation
-
-
lysine metabolism
-
-
macrolide antibiotic biosynthesis
-
-
malate/L-aspartate shuttle pathway
-
-
MALATE-ASPARTATE-SHUTTLE-PWY
maltose degradation
-
-
MALTOSECAT-PWY
mandelate degradation I
-
-
PWY-1501
manganese oxidation I
-
-
PWY-6591
mangrove triterpenoid biosynthesis
-
-
PWY-6109
mannitol biosynthesis
-
-
PWY-3881
mannitol cycle
-
-
PWY-6531
mannitol degradation I
-
-
MANNIDEG-PWY
mannitol degradation II
-
-
PWY-3861
Mannose type O-glycan biosynthesis
-
-
mannosylglycerate biosynthesis
-
-
mannosylglycerate biosynthesis I
-
-
PWY-5656
maresin biosynthesis
-
-
PWY-8356
matairesinol biosynthesis
-
-
PWY-5466
melatonin degradation I
-
-
PWY-6398
melatonin degradation II
-
-
PWY-6399
melibiose degradation
-
-
PWY0-1301
menaquinol-4 biosynthesis II
-
-
PWY-7998
menthol biosynthesis
-
-
PWY-3061
Metabolic pathways
-
-
metabolism of amino sugars and derivatives
-
-
metabolism of disaccharids
-
-
Metabolism of xenobiotics by cytochrome P450
-
-
Methane metabolism
-
-
methane metabolism
-
-
methane oxidation to methanol I
-
-
PWY-1641
Methanobacterium thermoautotrophicum biosynthetic metabolism
-
-
PWY-6146
methanofuran biosynthesis
-
-
PWY-5254
methanogenesis from acetate
-
-
METH-ACETATE-PWY
methanogenesis from CO2
-
-
methanogenesis from H2 and CO2
-
-
METHANOGENESIS-PWY
methanogenesis from methanol
-
-
CO2FORM-PWY
methanol oxidation to carbon dioxide
-
-
PWY-7616
methanol oxidation to formaldehyde IV
-
-
PWY-5506
methiin metabolism
-
-
PWY-7614
methionine metabolism
-
-
methoxylated aromatic compound degradation II
-
-
PWY-8305
methyl indole-3-acetate interconversion
-
-
PWY-6303
methyl ketone biosynthesis (engineered)
-
-
PWY-7007
methyl parathion degradation
-
-
PWY-5489
methyl phomopsenoate biosynthesis
-
-
PWY-7721
methyl tert-butyl ether degradation
-
-
PWY-7779
methyl-coenzyme M oxidation to CO2
-
-
PWY-5209
methyl-coenzyme M reduction to methane
-
-
METHFORM-PWY
methylamine degradation II
-
-
PWY-6965
methylaspartate cycle
methylerythritol phosphate pathway I
-
-
NONMEVIPP-PWY
methylerythritol phosphate pathway II
-
-
PWY-7560
methylgallate degradation
-
-
METHYLGALLATE-DEGRADATION-PWY
methylglyoxal degradation
-
-
methylglyoxal degradation I
-
-
PWY-5386
methylglyoxal degradation III
-
-
PWY-5453
methylglyoxal degradation V
-
-
PWY-5458
methylglyoxal degradation VI
-
-
MGLDLCTANA-PWY
methylglyoxal degradation VIII
-
-
PWY-5386-1
methylsalicylate biosynthesis
-
-
PWY18C3-22
methylsalicylate degradation
-
-
PWY-6184, PWY18C3-24
methylwyosine biosynthesis
-
-
PWY-7285
mevalonate degradation
-
-
PWY-5074
mevalonate metabolism
-
-
mevalonate pathway I (eukaryotes and bacteria)
-
-
PWY-922
mevalonate pathway II (haloarchaea)
-
-
PWY-6174
mevalonate pathway III (Thermoplasma)
-
-
PWY-7524
mevalonate pathway IV (archaea)
-
-
PWY-8125
Microbial metabolism in diverse environments
-
-
mineralocorticoid biosynthesis
-
-
PWY66-382
mitochondrial L-carnitine shuttle
-
-
PWY-6111
mitochondrial NADPH production (yeast)
-
-
PWY-7269
mixed acid fermentation
-
-
FERMENTATION-PWY
molybdenum cofactor biosynthesis
-
-
molybdenum cofactor sulfulylation (eukaryotes)
-
-
PWY-5963
molybdopterin biosynthesis
-
-
PWY-6823
momilactone A biosynthesis
-
-
PWY-7477
mono-trans, poly-cis decaprenyl phosphate biosynthesis
-
-
PWY-6383
monoacylglycerol metabolism (yeast)
-
-
PWY-7420
Monobactam biosynthesis
-
-
monoterpene biosynthesis
-
-
PWY-3041
Monoterpenoid biosynthesis
morphine biosynthesis
mRNA capping I
-
-
PWY-7375
mRNA capping II
-
-
PWY-7379
mucin core 1 and core 2 O-glycosylation
-
-
PWY-7433
mucin core 3 and core 4 O-glycosylation
-
-
PWY-7435
Mucin type O-glycan biosynthesis
-
-
mupirocin biosynthesis
-
-
PWY-8012
muropeptide degradation
-
-
PWY0-1546
mycobacterial sulfolipid biosynthesis
-
-
PWY-7746
mycobactin biosynthesis
-
-
PWY185E-1
mycolate biosynthesis
-
-
PWYG-321
mycolyl-arabinogalactan-peptidoglycan complex biosynthesis
-
-
PWY-6397
mycothiol biosynthesis
-
-
PWY1G-0
mycothiol oxidation
-
-
PWY1G-126
myo-inositol biosynthesis
myo-inositol degradation I
-
-
P562-PWY
N-3-oxalyl-L-2,3-diaminopropanoate biosynthesis
-
-
PWY-8071
N-acetyl-D-galactosamine degradation
-
-
PWY-7077
N-acetylglucosamine degradation I
-
-
GLUAMCAT-PWY
N-acetylglucosamine degradation II
-
-
PWY-6517
N-acetylneuraminate and N-acetylmannosamine degradation I
-
-
PWY0-1324
N-acetylneuraminate and N-acetylmannosamine degradation II
-
-
PWY-7581
N-end rule pathway I (prokaryotic)
-
-
PWY-7801
N-Glycan biosynthesis
-
-
N-hydroxy-L-pipecolate biosynthesis
-
-
PWY-7861
N-methylpyrrolidone degradation
-
-
PWY-7978
N1-methyl-N3-aminocarboxypropyl-pseudouridine-modified rRNA biosynthesis
-
-
PWY-8341
NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde
-
-
PWY-5653
NAD biosynthesis from nicotinamide
-
-
NAD-BIOSYNTHESIS-III
NAD de novo biosynthesis I
-
-
PYRIDNUCSYN-PWY
NAD de novo biosynthesis III
-
-
PWY-8352
NAD de novo biosynthesis IV (anaerobic)
-
-
PWY-8277
NAD metabolism
-
-
NAD phosphorylation and dephosphorylation
-
-
NADPHOS-DEPHOS-PWY
NAD phosphorylation and transhydrogenation
-
-
NADPHOS-DEPHOS-PWY-1
NAD salvage (plants)
-
-
PWY-5381
NAD salvage pathway I (PNC VI cycle)
-
-
PYRIDNUCSAL-PWY
NAD salvage pathway II (PNC IV cycle)
-
-
PWY-7761
NAD salvage pathway III (to nicotinamide riboside)
-
-
NAD-BIOSYNTHESIS-II
NAD salvage pathway IV (from nicotinamide riboside)
-
-
PWY3O-4106
NAD salvage pathway V (PNC V cycle)
-
-
PWY3O-4107
NAD(P)/NADPH interconversion
-
-
PWY-5083
NADH repair (eukaryotes)
-
-
PWY-6938
NADH repair (prokaryotes)
-
-
PWY-6938-1
NADH to cytochrome bd oxidase electron transfer I
-
-
PWY0-1334
NADH to cytochrome bd oxidase electron transfer II
-
-
PWY0-1568
NADH to cytochrome bo oxidase electron transfer I
-
-
PWY0-1335
NADH to cytochrome bo oxidase electron transfer II
-
-
PWY0-1567
NADH to dimethyl sulfoxide electron transfer
-
-
PWY0-1348
NADH to fumarate electron transfer
-
-
PWY0-1336
NADP biosynthesis
-
-
PWY-8148
NADPH repair (eukaryotes)
-
-
PWY-8137
NADPH repair (prokaryotes)
-
-
PWY-8136
NADPH to cytochrome c oxidase via plastocyanin
-
-
PWY-8271
Naphthalene degradation
-
-
naphthalene degradation (aerobic)
-
-
PWY-5427
naringenin biosynthesis (engineered)
-
-
PWY-7397
neolacto-series glycosphingolipids biosynthesis
-
-
PWY-7841
neolinustatin bioactivation
-
-
PWY-7092
Neomycin, kanamycin and gentamicin biosynthesis
-
-
neurosporaxanthin biosynthesis
-
-
PWY-6681
Nicotinate and nicotinamide metabolism
-
-
nicotine biosynthesis
-
-
PWY-5316
nicotine degradation I (pyridine pathway)
-
-
P181-PWY
nicotine degradation IV
-
-
PWY66-201
nicotine degradation V
-
-
PWY66-221
nitrate assimilation
-
-
nitrate reduction I (denitrification)
-
-
DENITRIFICATION-PWY
nitrate reduction II (assimilatory)
-
-
PWY-381
nitrate reduction III (dissimilatory)
-
-
PWY0-1321
nitrate reduction IV (dissimilatory)
-
-
PWY-5674
nitrate reduction IX (dissimilatory)
-
-
PWY0-1581
nitrate reduction VII (denitrification)
-
-
PWY-6748
nitrate reduction VIII (dissimilatory)
-
-
PWY0-1352
nitrate reduction VIIIb (dissimilatory)
-
-
PWY0-1573
nitrate reduction X (dissimilatory, periplasmic)
-
-
PWY0-1584
nitric oxide biosynthesis II (mammals)
-
-
PWY-4983
nitrifier denitrification
-
-
PWY-7084
nitrite-dependent anaerobic methane oxidation
-
-
PWY-6523
nitroethane degradation
-
-
PWY-5355
nitrogen fixation I (ferredoxin)
-
-
N2FIX-PWY
Nitrogen metabolism
-
-
nitrogen remobilization from senescing leaves
-
-
PWY-6549
Nitrotoluene degradation
-
-
nocardicin A biosynthesis
-
-
PWY-7797
noradrenaline and adrenaline degradation
-
-
PWY-6342
norspermidine biosynthesis
-
-
PWY-6562
noscapine biosynthesis
-
-
PWY-7138
Novobiocin biosynthesis
-
-
nucleoside and nucleotide degradation (archaea)
-
-
PWY-5532
O-antigen biosynthesis
-
-
O-antigen building blocks biosynthesis (E. coli)
-
-
OANTIGEN-PWY
O-Antigen nucleotide sugar biosynthesis
-
-
o-diquinones biosynthesis
-
-
PWY-6752
octane oxidation
octanoyl-[acyl-carrier protein] biosynthesis (mitochondria, yeast)
-
-
PWY-7388
octopamine biosynthesis
-
-
PWY-7297
odd iso-branched-chain fatty acid biosynthesis
-
-
PWY-8174
oleandomycin activation/inactivation
-
-
PWY-6972
oleate beta-oxidation
-
-
PWY0-1337
oleate beta-oxidation (isomerase-dependent, yeast)
-
-
PWY-7291
oleate beta-oxidation (reductase-dependent, yeast)
-
-
PWY-7307
oleate beta-oxidation (thioesterase-dependent, yeast)
-
-
PWY-7292
oleate biosynthesis I (plants)
-
-
PWY-5147
oleate biosynthesis II (animals and fungi)
-
-
PWY-5996
oleate biosynthesis III (cyanobacteria)
-
-
PWY-7587
oleate biosynthesis IV (anaerobic)
-
-
PWY-7664
oleoresin monoterpene volatiles biosynthesis
-
-
PWY-5423
omega-sulfo-II-dihydromenaquinone-9 biosynthesis
-
-
PWY-7781
One carbon pool by folate
-
-
ophiobolin F biosynthesis
-
-
PWY-7720
ophthalmate biosynthesis
-
-
PWY-8043
ornithine metabolism
-
-
orthanilate degradation
-
-
2ASDEG-PWY
Other glycan degradation
-
-
Other types of O-glycan biosynthesis
-
-
oxalate degradation II
-
-
PWY-6695
oxalate degradation III
-
-
PWY-6696
oxalate degradation IV
-
-
PWY-6697
oxalate degradation V
-
-
PWY-6698
oxalate degradation VI
-
-
PWY-7985
oxidative decarboxylation of pyruvate
-
-
Oxidative phosphorylation
-
-
oxidative phosphorylation
-
-
palmatine biosynthesis
-
-
PWY-5470
palmitate biosynthesis
-
-
palmitate biosynthesis I (type I fatty acid synthase)
-
-
PWY-5994
palmitate biosynthesis II (type II fatty acid synthase)
-
-
PWY-5971
palmitate biosynthesis III
-
-
PWY-8279
palmitoleate biosynthesis I (from (5Z)-dodec-5-enoate)
-
-
PWY-6282
palmitoleate biosynthesis II (plants and bacteria)
-
-
PWY-5366
palmitoleate biosynthesis III (cyanobacteria)
-
-
PWY-7589
palmitoleate biosynthesis IV (fungi and animals)
-
-
PWY3O-1801
palmitoyl ethanolamide biosynthesis
-
-
PWY-8055
Pantothenate and CoA biosynthesis
-
-
pantothenate biosynthesis
-
-
paraoxon degradation
-
-
PWY-5490
parathion degradation
-
-
PARATHION-DEGRADATION-PWY
partial TCA cycle (obligate autotrophs)
-
-
PWY-5913
paspaline biosynthesis
-
-
PWY-7492
patulin biosynthesis
-
-
PWY-7490
pectin degradation I
-
-
PWY-7246
pectin degradation II
-
-
PWY-7248
pederin biosynthesis
-
-
PWY-8049
Penicillin and cephalosporin biosynthesis
-
-
pentachlorophenol degradation
-
-
PCPDEG-PWY
pentacyclic triterpene biosynthesis
-
-
PWY-7251
Pentose and glucuronate interconversions
-
-
Pentose phosphate pathway
-
-
pentose phosphate pathway
-
-
pentose phosphate pathway (non-oxidative branch) I
-
-
NONOXIPENT-PWY
pentose phosphate pathway (non-oxidative branch) II
-
-
PWY-8178
pentose phosphate pathway (oxidative branch) I
-
-
OXIDATIVEPENT-PWY
pentose phosphate pathway (partial)
-
-
P21-PWY
peptido-conjugates in tissue regeneration biosynthesis
-
-
PWY-8355
Peptidoglycan biosynthesis
-
-
peptidoglycan biosynthesis
-
-
peptidoglycan biosynthesis I (meso-diaminopimelate containing)
-
-
PEPTIDOGLYCANSYN-PWY
peptidoglycan biosynthesis II (staphylococci)
-
-
PWY-5265
peptidoglycan biosynthesis III (mycobacteria)
-
-
PWY-6385
peptidoglycan biosynthesis IV (Enterococcus faecium)
-
-
PWY-6471
peptidoglycan biosynthesis V (beta-lactam resistance)
-
-
PWY-6470
peptidoglycan maturation (meso-diaminopimelate containing)
-
-
PWY0-1586
peptidoglycan recycling I
-
-
PWY0-1261
peptidoglycan recycling II
-
-
PWY-7883
perillyl aldehyde biosynthesis
-
-
PWY-6436
periplasmic disulfide bond formation
-
-
PWY0-1599
periplasmic disulfide bond reduction
-
-
PWY0-1600
petrobactin biosynthesis
-
-
PWY-6289
petroselinate biosynthesis
-
-
PWY-5367
Phenazine biosynthesis
-
-
phenol degradation
-
-
phenol degradation I (aerobic)
-
-
PWY-5418
phenolic malonylglucosides biosynthesis
-
-
PWY-6930
phenylacetate degradation (aerobic)
-
-
phenylacetate degradation I (aerobic)
-
-
PWY0-321
Phenylalanine metabolism
-
-
phenylalanine metabolism
-
-
Phenylalanine, tyrosine and tryptophan biosynthesis
-
-
phenylethanol biosynthesis
-
-
PWY-5751
phenylethylamine degradation I
-
-
2PHENDEG-PWY
phenylmercury acetate degradation
phenylpropanoid biosynthesis
-
-
PWY-361
Phenylpropanoid biosynthesis
-
-
phenylpropanoid biosynthesis
-
-
phenylpropanoid biosynthesis, initial reactions
-
-
PWY1F-467
phenylpropanoids methylation (ice plant)
-
-
PWY-7498
pheomelanin biosynthesis
-
-
PWY-7917
phloridzin biosynthesis
-
-
PWY-6515
phosphate acquisition
-
-
PWY-6348
phosphatidate biosynthesis (yeast)
-
-
PWY-7411
phosphatidate metabolism, as a signaling molecule
-
-
PWY-7039
phosphatidylcholine acyl editing
-
-
PWY-6803
phosphatidylcholine biosynthesis I
-
-
PWY3O-450
phosphatidylcholine biosynthesis II
-
-
PWY4FS-2
phosphatidylcholine biosynthesis III
-
-
PWY4FS-3
phosphatidylcholine biosynthesis IV
-
-
PWY4FS-4
phosphatidylcholine biosynthesis V
-
-
PWY-6825
phosphatidylcholine biosynthesis VI
-
-
PWY-6826
phosphatidylcholine biosynthesis VII
-
-
PWY-7470
phosphatidylcholine resynthesis via glycerophosphocholine
-
-
PWY-7367
phosphatidylethanolamine biosynthesis II
-
-
PWY4FS-6
phosphatidylethanolamine biosynthesis III
-
-
PWY-6273
phosphatidylethanolamine bioynthesis
-
-
phosphatidylglycerol biosynthesis I
-
-
PWY4FS-7
phosphatidylglycerol biosynthesis II
-
-
PWY4FS-8
phosphatidylinositol biosynthesis I (bacteria)
-
-
PWY-6580
phosphatidylinositol biosynthesis II (eukaryotes)
-
-
PWY-7625
phosphatidylinositol mannoside biosynthesis
-
-
PWY-7885
phosphatidylserine and phosphatidylethanolamine biosynthesis I
-
-
PWY-5669
phosphatidylserine biosynthesis I
-
-
PWY-7501
phosphatidylserine biosynthesis II
-
-
PWY-7506
phospholipases
-
-
LIPASYN-PWY
phospholipid desaturation
-
-
PWY-762
phospholipid remodeling (phosphatidate, yeast)
-
-
PWY-7417
phospholipid remodeling (phosphatidylcholine, yeast)
-
-
PWY-7416
phospholipid remodeling (phosphatidylethanolamine, yeast)
-
-
PWY-7409
Phosphonate and phosphinate metabolism
-
-
phosphonoacetate degradation
-
-
P483-PWY
phosphopantothenate biosynthesis I
-
-
PANTO-PWY
phosphopantothenate biosynthesis II
-
-
PWY-3961
phosphopantothenate biosynthesis III (archaea)
-
-
PWY-6654
photorespiration I
-
-
PWY-181
photorespiration II
-
-
PWY-8362
photorespiration III
-
-
PWY-8363
Photosynthesis
-
-
photosynthesis
-
-
photosynthesis light reactions
-
-
PWY-101
photosynthetic 3-hydroxybutanoate biosynthesis (engineered)
-
-
PWY-7218
phylloquinol biosynthesis
-
-
PWY-5027
phytate degradation I
-
-
PWY-4702
phytate degradation II
-
-
PWY-4781
phytochelatins biosynthesis
-
-
PWY-6745
phytochromobilin biosynthesis
-
-
PWY-7170
phytol degradation
-
-
PWY66-389
phytosterol biosynthesis (plants)
-
-
PWY-2541
pinitol biosynthesis I
-
-
PWY-6738
pinobanksin biosynthesis
-
-
PWY-5059
pinoresinol degradation
-
-
PWY-7982
plasmalogen biosynthesis I (aerobic)
-
-
PWY-7782
plasmalogen degradation
-
-
PWY-7783
plastoquinol-9 biosynthesis I
-
-
PWY-1581
plastoquinol-9 biosynthesis II
-
-
PWY-6978
platensimycin biosynthesis
-
-
PWY-8179
plaunotol biosynthesis
-
-
PWY-6691
poly(3-O-beta-D-glucopyranosyl-N-acetylgalactosamine 1-phosphate) wall teichoic acid biosynthesis
-
-
PWY-7819
poly(glycerol phosphate) wall teichoic acid biosynthesis
-
-
TEICHOICACID-PWY
poly(ribitol phosphate) wall teichoic acid biosynthesis I (B. subtilis)
-
-
PWY-7815
poly(ribitol phosphate) wall teichoic acid biosynthesis II (S. aureus)
-
-
PWY-7816
poly-hydroxy fatty acids biosynthesis
-
-
PWY-6710
polyamine pathway
-
-
polybrominated dihydroxylated diphenyl ethers biosynthesis
-
-
PWY-7934
Polycyclic aromatic hydrocarbon degradation
-
-
polyhydroxybutanoate biosynthesis
-
-
PWY1-3
polyhydroxydecanoate biosynthesis
-
-
PWY-6657
Polyketide sugar unit biosynthesis
-
-
polyphosphate metabolism
-
-
PWY-8138
porphyran degradation
-
-
PWY-6815
Porphyrin and chlorophyll metabolism
-
-
Porphyrin metabolism
-
-
ppGpp biosynthesis
-
-
ppGpp metabolism
-
-
PPGPPMET-PWY
preQ0 biosynthesis
-
-
PWY-6703
Primary bile acid biosynthesis
-
-
proanthocyanidins biosynthesis from flavanols
-
-
PWY-641
procollagen hydroxylation and glycosylation
-
-
PWY-7894
progesterone biosynthesis
-
-
PWY-7299
proline metabolism
-
-
proline to cytochrome bo oxidase electron transfer
-
-
PWY0-1544
propanethial S-oxide biosynthesis
-
-
PWY-5707
propanoate fermentation to 2-methylbutanoate
-
-
PWY-5109
Propanoate metabolism
-
-
propanol degradation
-
-
propanoyl CoA degradation I
-
-
PROPIONMET-PWY
propanoyl-CoA degradation II
-
-
PWY-7574
propionate fermentation
-
-
protectin biosynthesis
-
-
PWY-8357
protective electron sinks in the thylakoid membrane (PSII to PTOX)
-
-
PWY1YI0-7
protein citrullination
-
-
PWY-4921
protein N-glycosylation (Haloferax volcanii)
-
-
PWY-7661
protein N-glycosylation initial phase (eukaryotic)
-
-
MANNOSYL-CHITO-DOLICHOL-BIOSYNTHESIS
protein N-glycosylation processing of mannoproteins (cis-Golgi, yeast)
-
-
PWY-8323
protein N-glycosylation processing of proteins targeted for retention in cellular organelles (cis-Golgi, yeast)
-
-
PWY-8322
protein N-glycosylation processing phase (endoplasmic reticulum, yeast)
-
-
PWY-7918
protein N-glycosylation processing phase (plants and animals)
-
-
PWY-7919
protein NEDDylation
-
-
PWY-7899
protein O-mannosylation I (yeast)
-
-
PWY-7921
protein O-mannosylation II (mammals, core M1 and core M2)
-
-
PWY-7922
protein O-mannosylation III (mammals, core M3)
-
-
PWY-7979
protein O-[N-acetyl]-glucosylation
-
-
PWY-7437
protein Pupylation and dePupylation
-
-
PWY-7893
protein S-nitrosylation and denitrosylation
-
-
PWY-7798
protein SAMPylation and SAMP-mediated thiolation
-
-
PWY-7887
protein ubiquitination
-
-
PWY-7511
protocatechuate degradation I (meta-cleavage pathway)
-
-
P184-PWY
protocatechuate degradation III (para-cleavage pathway)
-
-
PWY-6336
PRPP biosynthesis
-
-
PWY0-662
pseudouridine degradation
-
-
PWY-6019
psilocybin biosynthesis
-
-
PWY-7936
purine deoxyribonucleosides degradation I
-
-
PWY-7179
purine deoxyribonucleosides degradation II
-
-
PWY-7179-1
purine deoxyribonucleosides salvage
-
-
PWY-7224
Purine metabolism
-
-
purine metabolism
-
-
purine nucleobases degradation I (anaerobic)
-
-
P164-PWY
purine nucleobases degradation II (anaerobic)
-
-
PWY-5497
purine ribonucleosides degradation
-
-
PWY0-1296
putrescine biosynthesis I
-
-
PWY-40
putrescine biosynthesis II
-
-
PWY-43
putrescine biosynthesis III
-
-
PWY-46
putrescine degradation I
-
-
PUTDEG-PWY
putrescine degradation III
-
-
PWY-0
putrescine degradation IV
-
-
PWY-2
putrescine degradation V
-
-
PWY-3
pyridoxal 5'-phosphate biosynthesis I
-
-
PYRIDOXSYN-PWY
pyridoxal 5'-phosphate biosynthesis II
-
-
PWY-6466
pyridoxal 5'-phosphate salvage I
-
-
PLPSAL-PWY
pyridoxal 5'-phosphate salvage II (plants)
-
-
PWY-7204
pyrimidine deoxyribonucleosides degradation
-
-
PWY-7181
pyrimidine deoxyribonucleosides salvage
-
-
PWY-7199
pyrimidine deoxyribonucleotide phosphorylation
-
-
PWY-7197
pyrimidine deoxyribonucleotides biosynthesis from CTP
-
-
PWY-7210
pyrimidine deoxyribonucleotides de novo biosynthesis I
-
-
PWY-7184
pyrimidine deoxyribonucleotides de novo biosynthesis II
-
-
PWY-7187
pyrimidine deoxyribonucleotides de novo biosynthesis III
-
-
PWY-6545
pyrimidine deoxyribonucleotides de novo biosynthesis IV
-
-
PWY-7198
pyrimidine deoxyribonucleotides dephosphorylation
-
-
PWY-7206
Pyrimidine metabolism
-
-
pyrimidine metabolism
-
-
pyrimidine nucleobases salvage I
-
-
PWY-7183
pyrimidine nucleobases salvage II
-
-
PWY-7194
pyrimidine ribonucleosides degradation
-
-
PWY0-1295
pyrimidine ribonucleosides salvage I
-
-
PWY-7193
pyrimidine ribonucleosides salvage II
-
-
PWY-6556
pyrimidine ribonucleosides salvage III
-
-
PWY-7195
pyruvate decarboxylation to acetyl CoA I
-
-
PYRUVDEHYD-PWY
pyruvate decarboxylation to acetyl CoA II
-
-
PWY-6970
pyruvate decarboxylation to acetyl CoA III
-
-
PWY-8275
pyruvate fermentation to (R)-acetoin I
-
-
PWY-5938
pyruvate fermentation to (R)-acetoin II
-
-
PWY-5939
pyruvate fermentation to (R)-lactate
-
-
PWY-8274
pyruvate fermentation to (S)-acetoin
-
-
PWY-6389
pyruvate fermentation to (S)-lactate
-
-
PWY-5481
pyruvate fermentation to acetate I
-
-
P142-PWY
pyruvate fermentation to acetate II
-
-
PWY-5482
pyruvate fermentation to acetate III
-
-
PWY-5483
pyruvate fermentation to acetate IV
-
-
PWY-5485
pyruvate fermentation to acetate V
-
-
PWY-5537
pyruvate fermentation to acetate VI
-
-
PWY-5538
pyruvate fermentation to acetate VII
-
-
PWY-5600
pyruvate fermentation to acetate VIII
-
-
PWY-5768
pyruvate fermentation to acetoin III
-
-
PWY3O-440
pyruvate fermentation to acetone
-
-
PWY-6588
pyruvate fermentation to butanoate
-
-
CENTFERM-PWY
pyruvate fermentation to butanol I
-
-
PWY-6583
pyruvate fermentation to butanol II (engineered)
-
-
PWY-6883
pyruvate fermentation to ethanol I
-
-
PWY-5480
pyruvate fermentation to ethanol II
-
-
PWY-5486
pyruvate fermentation to ethanol III
-
-
PWY-6587
pyruvate fermentation to hexanol (engineered)
-
-
PWY-6863
pyruvate fermentation to isobutanol (engineered)
-
-
PWY-7111
pyruvate fermentation to propanoate I
-
-
P108-PWY
Pyruvate metabolism
-
-
pyruvate to cytochrome bd oxidase electron transfer
-
-
PWY-7545
pyruvate to cytochrome bo oxidase electron transfer
-
-
PWY-7544
quercetin glucoside degradation (Allium)
-
-
PWY-7133
quercetin sulfate biosynthesis
-
-
PWY-6199
queuosine biosynthesis I (de novo)
-
-
PWY-6700
queuosine biosynthesis II (queuine salvage)
-
-
PWY-8105
queuosine biosynthesis III (queuosine salvage)
-
-
PWY-8106
quinate degradation
-
-
quinate degradation I
-
-
QUINATEDEG-PWY
quinate degradation II
-
-
PWY-6416
quinoxaline-2-carboxylate biosynthesis
-
-
PWY-7734
Rapoport-Luebering glycolytic shunt
-
-
PWY-6405
raspberry ketone biosynthesis
-
-
PWY-5393
reactive oxygen species degradation
-
-
DETOX1-PWY-1
reductive acetyl coenzyme A pathway
-
-
reductive acetyl coenzyme A pathway I (homoacetogenic bacteria)
-
-
CODH-PWY
reductive acetyl coenzyme A pathway II (autotrophic methanogens)
-
-
PWY-7784
reductive glycine pathway of autotrophic CO2 fixation
-
-
PWY-8303
reductive monocarboxylic acid cycle
-
-
PWY-5493
reductive TCA cycle I
-
-
P23-PWY
reductive TCA cycle II
-
-
PWY-5392
resolvin D biosynthesis
-
-
PWY66-397
retinoate biosynthesis I
-
-
PWY-6872
retinol biosynthesis
-
-
PWY-6857
Retinol metabolism
-
-
rhizobactin 1021 biosynthesis
-
-
PWY-761
Riboflavin metabolism
-
-
ribose phosphorylation
-
-
RIBOKIN-PWY
ricinoleate biosynthesis
-
-
PWY-7618
roseoflavin biosynthesis
-
-
PWY-7863
rosmarinic acid biosynthesis I
-
-
PWY-5048
rosmarinic acid biosynthesis II
-
-
PWY-5049
roxarsone degradation I
-
-
PWY-8260
rubber biosynthesis
-
-
PWY-5815
Rubisco shunt
-
-
PWY-5723
rutin degradation
-
-
PWY-6848
rutin degradation (plants)
-
-
PWY-7134
S-(6-hydroxy-4-methylhexan-4-yl)-L-cysteinylglycine biosynthesis
-
-
PWY-8301
S-(6-hydroxy-4-methylhexan-4-yl)-L-cysteinylglycine degradation
-
-
PWY-8302
S-adenosyl-L-methionine biosynthesis
-
-
SAM-PWY
S-adenosyl-L-methionine salvage I
-
-
PWY-6151
S-adenosyl-L-methionine salvage II
-
-
PWY-5041
S-methyl-5'-thioadenosine degradation I
-
-
PWY-6754
S-methyl-5'-thioadenosine degradation II
-
-
PWY-6756
S-methyl-5'-thioadenosine degradation III
-
-
PWY-6753
S-methyl-5'-thioadenosine degradation IV
-
-
PWY0-1391
S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation I
-
-
PWY-4361
S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation II
-
-
PWY-7174
S-methyl-5-thio-alpha-D-ribose 1-phosphate degradation III
-
-
PWY-8132
S-methyl-L-methionine cycle
-
-
PWY-5441
saframycin A biosynthesis
-
-
PWY-7671
salicin biosynthesis
-
-
PWY-6766
salicortin biosynthesis
-
-
PWY-6763
salicylate biosynthesis I
-
-
PWY-6406
salicylate biosynthesis II
-
-
PWY-8321
salicylate degradation I
-
-
PWY-6183
salidroside biosynthesis
-
-
PWY-6802
salinosporamide A biosynthesis
-
-
PWY-6627
Salmonella enterica serotype O:13 O antigen biosynthesis
-
-
PWY-8230
Salmonella enterica serotype O:54 O antigen biosynthesis
-
-
PWY-8204
salvigenin biosynthesis
-
-
PWY-7325
santalene biosynthesis II
-
-
PWY-6836
saponin biosynthesis II
-
-
PWY-5756
sciadonate biosynthesis
-
-
PWY-6598
scopoletin biosynthesis
-
-
PWY-6792
secologanin and strictosidine biosynthesis
-
-
PWY-5290
Secondary bile acid biosynthesis
-
-
sedoheptulose bisphosphate bypass
-
-
PWY0-1517
selenate reduction
-
-
PWY-6932
seleno-amino acid biosynthesis (plants)
-
-
PWY-6936
seleno-amino acid detoxification and volatilization I
-
-
PWY-6931
seleno-amino acid detoxification and volatilization II
-
-
PWY-6935
seleno-amino acid detoxification and volatilization III
-
-
PWY-6933
Selenocompound metabolism
-
-
selenocysteine biosynthesis
-
-
serine metabolism
-
-
serine racemization
-
-
PWY-8140
serotonin and melatonin biosynthesis
-
-
PWY-6030
serotonin degradation
-
-
PWY-6313
serotonin metabolism
-
-
sesamin biosynthesis
-
-
PWY-5469
Sesquiterpenoid and triterpenoid biosynthesis
-
-
shikimate degradation I
-
-
SHIKIMATEDEG-PWY
sitosterol degradation to androstenedione
-
-
PWY-6948
solasodine glycosylation
-
-
PWY18C3-4
sophorolipid biosynthesis
-
-
SOPHOROSYLOXYDOCOSANOATE-SYN-PWY
sophorosyloxydocosanoate deacetylation
-
-
SOPHOROSYLOXYDOCOSANOATE-DEG-PWY
sorbitol biosynthesis II
-
-
PWY-5530
sorgoleone biosynthesis
-
-
PWY-5987
spermidine biosynthesis I
-
-
BSUBPOLYAMSYN-PWY
spermidine biosynthesis II
-
-
PWY-6559
spermidine biosynthesis III
-
-
PWY-6834
spermine and spermidine degradation I
-
-
PWY-6117
spermine and spermidine degradation II
-
-
PWY-6440
spermine and spermidine degradation III
-
-
PWY-6441
spermine biosynthesis
-
-
ARGSPECAT-PWY
sphingolipid biosynthesis (mammals)
-
-
PWY-7277
sphingolipid biosynthesis (plants)
-
-
PWY-5129
sphingolipid biosynthesis (yeast)
-
-
SPHINGOLIPID-SYN-PWY
Sphingolipid metabolism
-
-
sphingomyelin metabolism
-
-
PWY3DJ-11281
sphingosine and sphingosine-1-phosphate metabolism
-
-
PWY3DJ-11470
sphingosine metabolism
-
-
Spodoptera littoralis pheromone biosynthesis
-
-
PWY-7656
spongiadioxin C biosynthesis
-
-
PWY-7935
sporopollenin precursors biosynthesis
-
-
PWY-6733
stachyose degradation
-
-
PWY-6527
staphyloferrin A biosynthesis
-
-
PWY-7990
staphylopine biosynthesis
-
-
PWY-8007
Starch and sucrose metabolism
-
-
starch biosynthesis
-
-
PWY-622
starch degradation
-
-
starch degradation I
-
-
PWY-842
starch degradation II
-
-
PWY-6724
starch degradation III
-
-
PWY-6731
starch degradation IV
-
-
PWY-6735
starch degradation V
-
-
PWY-6737
stearate biosynthesis I (animals)
-
-
PWY-5972
stearate biosynthesis II (bacteria and plants)
-
-
PWY-5989
stearate biosynthesis III (fungi)
-
-
PWY3O-355
stearate biosynthesis IV
-
-
PWY-8280
stellatic acid biosynthesis
-
-
PWY-7736
sterculate biosynthesis
-
-
PWY-4942
Steroid biosynthesis
-
-
Steroid degradation
-
-
Steroid hormone biosynthesis
-
-
sterol biosynthesis (methylotrophs)
-
-
PWY-8026
sterol:steryl ester interconversion (yeast)
-
-
PWY-7424
stigma estolide biosynthesis
-
-
PWY-6453
Stilbenoid, diarylheptanoid and gingerol biosynthesis
-
-
streptomycin biosynthesis
-
-
PWY-5940
Streptomycin biosynthesis
-
-
streptorubin B biosynthesis
-
-
PWY1A0-6120
Styrene degradation
-
-
suberin monomers biosynthesis
succinate to chytochrome c oxidase via cytochrome c6
-
-
PWY1YI0-2
succinate to cytochrome bd oxidase electron transfer
-
-
PWY0-1353
succinate to cytochrome bo oxidase electron transfer
-
-
PWY0-1329
succinate to cytochrome c oxidase via plastocyanin
-
-
PWY1YI0-3
succinate to plastoquinol oxidase
-
-
PWY1YI0-8
sucrose biosynthesis I (from photosynthesis)
-
-
SUCSYN-PWY
sucrose biosynthesis II
-
-
PWY-7238
sucrose biosynthesis III
-
-
PWY-7347
sucrose degradation I (sucrose phosphotransferase)
-
-
SUCUTIL-PWY
sucrose degradation II (sucrose synthase)
-
-
PWY-3801
sucrose degradation III (sucrose invertase)
-
-
PWY-621
sucrose degradation IV (sucrose phosphorylase)
-
-
PWY-5384
sucrose degradation V (sucrose alpha-glucosidase)
-
-
PWY66-373
sucrose degradation VII (sucrose 3-dehydrogenase)
-
-
SUCROSEUTIL2-PWY
sulfate activation for sulfonation
-
-
PWY-5340
sulfate reduction
-
-
sulfated glycosaminoglycan metabolism
-
-
sulfide oxidation I (to sulfur globules)
-
-
P222-PWY
sulfide oxidation III (to sulfite)
-
-
PWY-5285
sulfide oxidation IV (mitochondria)
-
-
PWY-7927
sulfite oxidation II
-
-
PWY-5279
sulfite oxidation III
-
-
PWY-5278
sulfite oxidation IV (sulfite oxidase)
-
-
PWY-5326
sulfoacetaldehyde degradation I
-
-
PWY-1281
sulfolactate degradation II
-
-
PWY-6637
sulfolactate degradation III
-
-
PWY-6638
sulfopterin metabolism
-
-
Sulfur metabolism
-
-
sulfur volatiles biosynthesis
-
-
PWY-6736
superoxide radicals degradation
-
-
DETOX1-PWY
superpathway of (Kdo)2-lipid A biosynthesis
-
-
KDO-NAGLIPASYN-PWY
superpathway of 5-aminoimidazole ribonucleotide biosynthesis
-
-
PWY-6277
superpathway of coenzyme A biosynthesis III (mammals)
-
-
COA-PWY-1
superpathway of dimethylsulfoniopropanoate degradation
-
-
PWY-6049
superpathway of fatty acid biosynthesis initiation
-
-
FASYN-INITIAL-PWY
superpathway of fermentation (Chlamydomonas reinhardtii)
-
-
PWY4LZ-257
superpathway of glucose and xylose degradation
-
-
PWY-6901
superpathway of glycolysis and the Entner-Doudoroff pathway
-
-
GLYCOLYSIS-E-D
superpathway of glycolysis, pyruvate dehydrogenase, TCA, and glyoxylate bypass
-
-
GLYCOLYSIS-TCA-GLYOX-BYPASS
superpathway of glyoxylate cycle and fatty acid degradation
-
-
PWY-561
superpathway of L-aspartate and L-asparagine biosynthesis
-
-
ASPASN-PWY
superpathway of methylsalicylate metabolism
-
-
PWY18C3-25
superpathway of mycolate biosynthesis
-
-
PWY-6113
superpathway of nicotine biosynthesis
-
-
PWY-7342
superpathway of ornithine degradation
-
-
ORNDEG-PWY
superpathway of phospholipid biosynthesis II (plants)
-
-
PHOSLIPSYN2-PWY
superpathway of photosynthetic hydrogen production
-
-
PWY-7731
superpathway of polyamine biosynthesis II
-
-
POLYAMINSYN3-PWY
superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis (E. coli)
-
-
PWY0-166
superpathway of UDP-glucose-derived O-antigen building blocks biosynthesis
-
-
PWY-7328
superpathway of UDP-N-acetylglucosamine-derived O-antigen building blocks biosynthesis
-
-
PWY-7332
syringate degradation
-
-
PWY-6339
Taurine and hypotaurine metabolism
-
-
taurine biosynthesis I
-
-
PWY-5331
taurine biosynthesis II
-
-
PWY-7850
taurine biosynthesis III
-
-
PWY-8359
taurine degradation
-
-
taurine degradation IV
-
-
PWY0-981
TCA cycle I (prokaryotic)
-
-
TCA
TCA cycle II (plants and fungi)
-
-
PWY-5690
TCA cycle III (animals)
-
-
PWY66-398
TCA cycle IV (2-oxoglutarate decarboxylase)
-
-
P105-PWY
TCA cycle V (2-oxoglutarate synthase)
-
-
PWY-6969
TCA cycle VI (Helicobacter)
-
-
REDCITCYC
TCA cycle VII (acetate-producers)
-
-
PWY-7254
TCA cycle VIII (Chlamydia)
-
-
TCA-1
teichuronic acid biosynthesis (B. subtilis 168)
-
-
PWY-7820
terminal O-glycans residues modification (via type 2 precursor disaccharide)
-
-
PWY-7434
Terpenoid backbone biosynthesis
-
-
testosterone and androsterone degradation to androstendione (aerobic)
-
-
PWY-6943
tetracenomycin C biosynthesis
-
-
PWY-7485
tetrachloroethene degradation
-
-
PCEDEG-PWY
tetradecanoate biosynthesis (mitochondria)
-
-
PWY66-430
tetrahydrofolate biosynthesis I
-
-
PWY-6614
tetrahydrofolate biosynthesis II
-
-
PWY2DNV-11
tetrahydrofolate metabolism
-
-
tetrahydrofolate salvage from 5,10-methenyltetrahydrofolate
-
-
PWY-6613
tetrahydromonapterin biosynthesis
-
-
PWY0-1433
tetrahydropteridine recycling
-
-
PWY-8099
tetrahydroxyxanthone biosynthesis (from benzoate)
-
-
PWY-5001
tetrapyrrole biosynthesis I (from glutamate)
-
-
PWY-5188
tetrapyrrole biosynthesis II (from glycine)
-
-
PWY-5189
the visual cycle I (vertebrates)
-
-
PWY-6861
theobromine biosynthesis I
-
-
PWY-5039
theophylline degradation
-
-
PWY-6999
thiamine diphosphate biosynthesis I (E. coli)
-
-
PWY-6894
thiamine diphosphate biosynthesis II (Bacillus)
-
-
PWY-6893
thiamine diphosphate biosynthesis III (Staphylococcus)
-
-
PWY-6907
thiamine diphosphate biosynthesis IV (eukaryotes)
-
-
PWY-6908
thiamine diphosphate salvage I
-
-
PWY-6896
thiamine diphosphate salvage II
-
-
PWY-6897
thiamine diphosphate salvage III
-
-
PWY-6898
thiamine diphosphate salvage IV (yeast)
-
-
PWY-7356
Thiamine metabolism
-
-
thiamine phosphate formation from pyrithiamine and oxythiamine (yeast)
-
-
PWY-7357
thiamine triphosphate metabolism
-
-
PWY-7369
thiazole component of thiamine diphosphate biosynthesis I
-
-
PWY-6892
thioredoxin pathway
-
-
THIOREDOX-PWY
thiosulfate disproportionation IV (rhodanese)
-
-
PWY-5350
threo-tetrahydrobiopterin biosynthesis
-
-
PWY-6983
threonine metabolism
-
-
thymine degradation
-
-
PWY-6430
thyroid hormone biosynthesis
thyroid hormone metabolism I (via deiodination)
-
-
PWY-6260
thyroid hormone metabolism II (via conjugation and/or degradation)
-
-
PWY-6261
Toluene degradation
-
-
toluene degradation II (aerobic) (via 4-methylcatechol)
-
-
TOLUENE-DEG-3-OH-PWY
toluene degradation to 2-hydroxypentadienoate (via toluene-cis-diol)
-
-
TOLUENE-DEG-DIOL-PWY
toluene degradation to 2-hydroxypentadienoate I (via o-cresol)
-
-
TOLUENE-DEG-2-OH-PWY
toluene degradation to benzoate
-
-
TOLUENE-DEG-CATECHOL-PWY
toxoflavin biosynthesis
-
-
PWY-7991
trans, trans-farnesyl diphosphate biosynthesis
-
-
PWY-5123
trans-3-hydroxy-L-proline degradation
-
-
PWY-7515
trans-4-hydroxy-L-proline degradation I
-
-
HYDROXYPRODEG-PWY
trans-caffeate degradation (aerobic)
-
-
PWY-8003
trans-lycopene biosynthesis II (oxygenic phototrophs and green sulfur bacteria)
-
-
PWY-6475
traumatin and (Z)-3-hexen-1-yl acetate biosynthesis
-
-
PWY-5410
trehalose biosynthesis I
-
-
TRESYN-PWY
trehalose biosynthesis II
-
-
PWY-881
trehalose biosynthesis III
-
-
TREHALOSESYN-PWY
trehalose biosynthesis IV
-
-
PWY-2622
trehalose biosynthesis V
-
-
PWY-2661
trehalose degradation I (low osmolarity)
-
-
TREDEGLOW-PWY
trehalose degradation II (cytosolic)
-
-
PWY0-1182
trehalose degradation IV
-
-
PWY-2722
trehalose degradation V
-
-
PWY-2723
trehalose degradation VI (periplasmic)
-
-
PWY0-1466
triacylglycerol degradation
-
-
LIPAS-PWY
tricin biosynthesis
-
-
PWY-7995
trimethylamine degradation
-
-
PWY-6968
trimethylamine N-oxide biosynthesis
-
-
PWY-8292
tRNA charging
-
-
TRNA-CHARGING-PWY
tRNA methylation (yeast)
-
-
PWY-6829
tRNA processing
-
-
PWY0-1479
tRNA splicing I
-
-
PWY-6689
tRNA splicing II
-
-
PWY-7803
tRNA-uridine 2-thiolation (cytoplasmic)
-
-
PWY-7888
tRNA-uridine 2-thiolation and selenation (bacteria)
-
-
PWY-7892
tropane alkaloid biosynthesis
-
-
tropane alkaloids biosynthesis
-
-
PWY-5317
Tropane, piperidine and pyridine alkaloid biosynthesis
-
-
trypanothione biosynthesis
-
-
TRYPANOSYN-PWY
Tryptophan metabolism
-
-
tryptophan metabolism
-
-
tunicamycin biosynthesis
-
-
PWY-7821
type I lipoteichoic acid biosynthesis (S. aureus)
-
-
PWY-7817
type IV lipoteichoic acid biosynthesis (S. pneumoniae)
-
-
PWY-7818
Tyrosine metabolism
-
-
tyrosine metabolism
-
-
ubiquinol-10 biosynthesis (early decarboxylation)
-
-
PWY-5857
ubiquinol-10 biosynthesis (late decarboxylation)
-
-
PWY-5872
ubiquinol-6 biosynthesis (late decarboxylation)
-
-
PWY3O-19
ubiquinol-6 biosynthesis from 4-aminobenzoate (yeast)
-
-
PWY-7230
ubiquinol-7 biosynthesis (early decarboxylation)
-
-
PWY-5855
ubiquinol-7 biosynthesis (late decarboxylation)
-
-
PWY-5873
ubiquinol-8 biosynthesis (early decarboxylation)
-
-
PWY-6708
ubiquinol-8 biosynthesis (late decarboxylation)
-
-
PWY-5870
ubiquinol-9 biosynthesis (early decarboxylation)
-
-
PWY-5856
ubiquinol-9 biosynthesis (late decarboxylation)
-
-
PWY-5871
Ubiquinone and other terpenoid-quinone biosynthesis
-
-
ubiquinone biosynthesis
-
-
UDP-alpha-D-galactofuranose biosynthesis
-
-
PWY-7622
UDP-alpha-D-galactose biosynthesis
-
-
PWY-7344
UDP-alpha-D-glucose biosynthesis
-
-
PWY-7343
UDP-alpha-D-glucuronate biosynthesis (from myo-inositol)
-
-
PWY-4841
UDP-alpha-D-glucuronate biosynthesis (from UDP-glucose)
-
-
PWY-7346
UDP-beta-L-rhamnose biosynthesis
-
-
PWY-3261
UDP-GlcNAc biosynthesis
-
-
UDP-N-acetyl-alpha-D-mannosaminouronate biosynthesis
-
-
PWY-7335
UDP-N-acetyl-beta-L-fucosamine biosynthesis
-
-
PWY-7330
UDP-N-acetyl-beta-L-quinovosamine biosynthesis
-
-
PWY-7331
UDP-N-acetyl-D-galactosamine biosynthesis I
-
-
PWY-5512
UDP-N-acetyl-D-galactosamine biosynthesis II
-
-
PWY-5514
UDP-N-acetyl-D-galactosamine biosynthesis III
-
-
PWY-8013
UDP-N-acetyl-D-glucosamine biosynthesis I
-
-
UDPNAGSYN-PWY
UDP-N-acetyl-D-glucosamine biosynthesis II
-
-
UDPNACETYLGALSYN-PWY
UDP-N-acetylmuramoyl-pentapeptide biosynthesis I (meso-diaminopimelate containing)
-
-
PWY-6387
UDP-N-acetylmuramoyl-pentapeptide biosynthesis II (lysine-containing)
-
-
PWY-6386
UDP-N-acetylmuramoyl-pentapeptide biosynthesis III (meso-diaminopimelate containing)
-
-
PWY-7953
ultra-long-chain fatty acid biosynthesis
-
-
PWY-8041
UMP biosynthesis I
-
-
PWY-5686
UMP biosynthesis II
-
-
PWY-7790
UMP biosynthesis III
-
-
PWY-7791
uracil degradation I (reductive)
-
-
PWY-3982
urate conversion to allantoin I
-
-
PWY-5691
urate conversion to allantoin II
-
-
PWY-7394
urate conversion to allantoin III
-
-
PWY-7849
urea cycle
urea degradation I
-
-
PWY-5703
urea degradation II
-
-
PWY-5704
UTP and CTP de novo biosynthesis
-
-
PWY-7176
UTP and CTP dephosphorylation I
-
-
PWY-7185
UTP and CTP dephosphorylation II
-
-
PWY-7177
valine metabolism
-
-
Valine, leucine and isoleucine biosynthesis
-
-
Valine, leucine and isoleucine degradation
-
-
valproate beta-oxidation
-
-
PWY-8182
vancomycin resistance I
-
-
PWY-6454
vancomycin resistance II
-
-
PWY-6455
vanillin and vanillate degradation I
-
-
PWY-7097
vanillin and vanillate degradation II
-
-
PWY-7098
vanillin biosynthesis I
-
-
PWY-5665
Various types of N-glycan biosynthesis
-
-
vernolate biosynthesis III
-
-
PWY-6917
very long chain fatty acid biosynthesis I
-
-
PWY-5080
very long chain fatty acid biosynthesis II
-
-
PWY-7036
vindoline, vindorosine and vinblastine biosynthesis
-
-
PWY-5292
viridicatumtoxin biosynthesis
-
-
PWY-7659
vitamin B1 metabolism
-
-
vitamin B12 metabolism
-
-
Vitamin B6 metabolism
-
-
vitamin B6 metabolism
-
-
vitamin D3 biosynthesis
-
-
PWY-6076
vitamin D3 metabolism
-
-
vitamin E biosynthesis (tocopherols)
-
-
PWY-1422
vitamin E biosynthesis (tocotrienols)
-
-
PWY-7436
vitamin E metabolism
-
-
vitamin K metabolism
-
-
vitamin K-epoxide cycle
volatile benzenoid biosynthesis I (ester formation)
-
-
PWY-4203
VTC2 cycle
-
-
PWY4FS-12
wax esters biosynthesis I
-
-
PWY-5884
wax esters biosynthesis II
-
-
PWY-5885
wogonin metabolism
-
-
PWY-7213
xanthine and xanthosine salvage
-
-
SALVPURINE2-PWY
xanthohumol biosynthesis
-
-
PWY-5135
xanthommatin biosynthesis
-
-
PWY-8249
Xylene degradation
-
-
xylitol degradation I
-
-
LARABITOLUTIL-PWY
xyloglucan degradation II (exoglucanase)
-
-
PWY-6807
Zeatin biosynthesis
-
-
zymosterol biosynthesis
-
-
PWY-6074
[2Fe-2S] iron-sulfur cluster biosynthesis
-
-
PWY-7250
top print hide
ORGANISM
COMMENTARY hide
LITERATURE
UNIPROT
SEQUENCE DB
SOURCE
top print hide
SOURCE TISSUE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
SOURCE
-
pheochromocytoma cell line
Manually annotated by BRENDA team
-
lymphoma cell, expression of enzyme is induced upon contact of cell with endothelial cells
Manually annotated by BRENDA team
-
lymphoma cell, expression of enzyme is induced upon contact of cell with endothelial cells. Enzyme expression is also induced following exposure to interleukins IL-4, IL-6, and IL-13, but not IL-1
Manually annotated by BRENDA team
-
tumor-induced dysregulation of endocytic activity of dendritic cells is mediated by reduced activity of several members of the small Rho GTPase family
Manually annotated by BRENDA team
-
fibroblast cell line
Manually annotated by BRENDA team
a4 is the dominant subunit a isoform expressed in these cells
Manually annotated by BRENDA team
-
mouse mammary tumor cell line
Manually annotated by BRENDA team
-
pheochromocytoma cell line
Manually annotated by BRENDA team
-
melanotic hybrid cell
Manually annotated by BRENDA team
-
melanotic hybrid cell
Manually annotated by BRENDA team
abdominal aortic aneurysm, PDE1C is not expressed in normal aorta
Manually annotated by BRENDA team
-
stellate cells
Manually annotated by BRENDA team
pre-adipocytes, predominantly
Manually annotated by BRENDA team
-
Y-1 cell, increased activity of catalase in tumor cells recombinantly overexpressing IGFBP-2 probably mediated through IGF-independent mechanisms
Manually annotated by BRENDA team
-
cell line R 1.1: wild-type, Sahn 12: mutant clone
Manually annotated by BRENDA team
-
NTPDase1 and NTPDase2
Manually annotated by BRENDA team
Tmprss2 and Tmprss4 are coexpressed in alveolar and bronchial regions
Manually annotated by BRENDA team
specialized cell that deposits tooth enamel
Manually annotated by BRENDA team
-
LOX is highly expressed in early gestational amnion tissue (12-14 weeks)
Manually annotated by BRENDA team
-
GRK2, no expression of GRK3
Manually annotated by BRENDA team
-
high expression rate
Manually annotated by BRENDA team
-
low-grade astrocytoma
Manually annotated by BRENDA team
KIF5B is concentrated in the central spindle during cytokinesis in both primary chondrocytes and chondrogenic ATDC5 cells
Manually annotated by BRENDA team
-
primary cell line, murine B-cells are isolated from spleen by a negative depletion
Manually annotated by BRENDA team
-
tumor-induced dysregulation of endocytic activity of dendritic cells is mediated by reduced activity of several members of the small Rho GTPase family
Manually annotated by BRENDA team
-
wild type, G2N2C and Tb3A transgenic BCC cell lines expressing Gli2 under the control of the keratin 5 promoter
Manually annotated by BRENDA team
receptor activator of nuclear factor kappa B ligand-differentiated, expression of CaMKI and CaMKIIgamma
Manually annotated by BRENDA team
Q920A7 and Q8JZQ2
radial astrocytes of the cerebellum
Manually annotated by BRENDA team
isoform CaMKII-beta is abundant in OFF bipolar cells, which form electrical synapses in the outer and the inner retina
Manually annotated by BRENDA team
-
Burkitt's lymphoma cell line
Manually annotated by BRENDA team
-
12, 16 and 20 weeks after initiation of BBN treatment: higher PyNpase level in invasive carcinoma and hyperplasia compared to controls
Manually annotated by BRENDA team
-
skeletal and nonskeletal tumor cell
Manually annotated by BRENDA team
ENPP2 is strongly down-regulated with age in stromal stem cells that produce osteoblasts and make bone. ENPP2 plays an important role in early osteoblast differentiation
Manually annotated by BRENDA team
-
mineral-associated fraction
Manually annotated by BRENDA team
first mandibular arch
Manually annotated by BRENDA team
epithelial cells of the bronchiole, PON1
Manually annotated by BRENDA team
-
CSD is expressed in the glandular epithelium of the bulbourethral gland
Manually annotated by BRENDA team
-
CD45-negative variant of BW5147
Manually annotated by BRENDA team
-
thymoma cell line served as host for vesicular stomatitis virus
Manually annotated by BRENDA team
-
C1300 neuroblastoma M1 clonal cell line
Manually annotated by BRENDA team
-
colon cancer cell
Manually annotated by BRENDA team
mammary gland epithelial cell line
Manually annotated by BRENDA team
-
mouse embryonic fibroblast cell oncogenically transformed with both E1A and ras, and containing wild-type p53
Manually annotated by BRENDA team
-
mouse embryonic fibroblast cell oncogenically transformed with both E1A and ras, and containing p53-/-
Manually annotated by BRENDA team
-
specific expression of SULT1E1
Manually annotated by BRENDA team
lysophosphatidylcholine acyltransferase 4 (LPCAT4) mRNA expression and LPCAT enzymatic activity towards oleoyl-, linoleoyl-, (5Z,8Z,11Z,14Z)-eicosatetraenoyl-, and docosahexaenoyl-CoA increases in the late stage of chondrogenic differentiation, when mineralization occurs
Manually annotated by BRENDA team
-
gamma-carboxylase gene targeting
Manually annotated by BRENDA team
-
colon 26 tumor cells transplanted in BALB/c mice
Manually annotated by BRENDA team
-
the enzyme is secreted into the apical medium of polarized cultures of rabbit connecting tubule and cortical collecting duct cells
Manually annotated by BRENDA team
from days 6 to 8 of pregnancy, the signals for Lox mRNA and protein are strongly detected in the decidual cells
Manually annotated by BRENDA team
-
the GD3 synthase gene may be involved in early tooth development, particularly in the proliferation of dental epithelium
Manually annotated by BRENDA team
-
thrombin induces a phosphoinositide 3-kinase-Akt pathway-dependent acquisition of dermal-sheath-like properties by dermal papilla cells in vitro, involving increased proliferation rate, acquisition of myofibroblastic contractile properties and a decreased capacity to sustain growth and survival of keratinocytes. The thrombin inhibitor protease nexin 1 regulates all those effects in vitro. Control of thrombin signaling interferes with hair follicle dermal cells plasticity to regulate their function
Manually annotated by BRENDA team
-
renal distal tubular epithelial cell line. CYP27B1 gene expression is unchanged after treatement with parathyroid hormone or after high Ca2+ exposure
Manually annotated by BRENDA team
-
level of enzyme mRNA and protein increases from testis to epididymis to ductus deferens, main cell types containing enzyme are Leydig cells of testis, epithelial cells and some stromal cells
Manually annotated by BRENDA team
fibre tracts of the encephalon, PON1
Manually annotated by BRENDA team
-
isozyme GC-B
Manually annotated by BRENDA team
-
specifically expressed in enteroendocrine cell of the murine colon and ileum
Manually annotated by BRENDA team
microglial cell
Manually annotated by BRENDA team
-
mouse endothelial cell line EOMA
Manually annotated by BRENDA team
-
cell line derived from FM3A
Manually annotated by BRENDA team
an asynchronously proliferating population of carcinoma cells
Manually annotated by BRENDA team
-
embryonal carcinoma cell
Manually annotated by BRENDA team
-
keratinized surface epithelium
Manually annotated by BRENDA team
-
of the stomach, mainly LOXL, mucous-secreting cells
Manually annotated by BRENDA team
a spermatocyte cell line
Manually annotated by BRENDA team
-
-
Manually annotated by BRENDA team
-
in the embryonic cortex, nestin-positive precursors and betaII-tubulin positive neurons from E12-E13 primary cortical precursor cell culture
Manually annotated by BRENDA team
-
U-1242 MG, N-Cadherin cleavage occurs at a higher level in glioblastoma cells than in non-neoplastic astrocytes
Manually annotated by BRENDA team
predominantly expressed on glomerular endothelial cells
Manually annotated by BRENDA team
in the kidney, constitutive Adamts5 expression in adult tissue
Manually annotated by BRENDA team
-
lowering cyclic adenosine-3',5'-monophosphate levels by expression of a cAMP-specific phosphodiesterase decreases intrinsic pulsatile gonadotropin-releasing hormone secretion from GT1 cells
Manually annotated by BRENDA team
-
COMT2 is highly expressed in sensory hair cells of the inner ear
Manually annotated by BRENDA team
activity is restricted to progenitor and precursor B cells. Enhanced BP-1 expression on virus-transformed pre-B cells and on normal pro-B cells stimulated by the interleukin 7 growth factor
Manually annotated by BRENDA team
from neonatal mice
Manually annotated by BRENDA team
-
PI4KIIalpha is strongly reduced in the nerve terminals of mocha hippocampal mossy fibers
Manually annotated by BRENDA team
-
immortalized hippocampal neuron
Manually annotated by BRENDA team
-
the mRNA expression of EXT2, one of the crucial enzymes for heparan sulfate-glycosaminoglycan synthesis, is markedly up-regulated in injured hypoglossal motor neurons after axotomy
Manually annotated by BRENDA team
-
isoform COMT2
Manually annotated by BRENDA team
diffuse labelling of
Manually annotated by BRENDA team
-
novel taste learning elicited biphasic (acute and long-tasting) activation of two distinct lysine acetyltransferase activities along with the EPK/MAPK cascade in insular cortex
Manually annotated by BRENDA team
-
simple, stratified, and pseudo-stratified epithelium of the integumentary system
Manually annotated by BRENDA team
-
isoform AC5
Manually annotated by BRENDA team
isoform Sulf1 level in the nucleus pulposus is higher compared with Sulf2 at the age of 1 and 6 months and significantly declines with aging
Manually annotated by BRENDA team
-
high relative expression of catE in adenomas and carcinomas relative to normal epithelium
Manually annotated by BRENDA team
-
-
Manually annotated by BRENDA team
-
P-LAP is located in the periphery in early gestation, located in both the periphery and inner cells during mid-gestation, located only in inner cells in late gestation
Manually annotated by BRENDA team
-
macrophage cell, infection with Mycobacterium bovis strain AS-1 lacking an arginine permease. AS-1 infection enhances enzyme activity in resting J774.1 cells. Intracellular growth of AS-1 is enhanced by inhibition of enzyme and of ornithine decarboxylase using L-norvaline and difluoromethylornithine treatment
Manually annotated by BRENDA team
-
STI571-resistant cells
Manually annotated by BRENDA team
MCA3D (non-tumorigenic keratinocytes) highest IKK alpha expression, PDVC57 (moderately carcinogenic keratinocytes) show an important reduction in IKK alpha expression, HACa4 cells (highly tumorigenic) expression of IKK alpha is almost absent
Manually annotated by BRENDA team
represents as much as 1% of total cytosolic protein in the kidney
Manually annotated by BRENDA team
KLN205-MUC1, lung cancer cell line, higher expression of beta3GnT7 in cancer cell lines with low degrees of invasiveness
Manually annotated by BRENDA team
-
-
Manually annotated by BRENDA team
-
oral cavity
Manually annotated by BRENDA team
-
cells express higher levels of cytosolic acetyl-CoA synthetase ACSS2 under hypoxia than normoxia. Knockdown of ACSS2 by RNA interference in tumor cells enhances tumor cell death under long-term hypoxia in vitro. The ACSS2 suppression slows tumor growth in vivo. Tumor cells excrete acetate and the quantity increases under hypoxia, the pattern of acetate excretion follows the expression pattern of ACSS2. The ACSS2 knockdown leads to a corresponding reduction in the acetate excretion in tumor cells
Manually annotated by BRENDA team
4 lung adenocarcinoma cell lines (KC1–KC4) from lung tumors in KC mice and 2 lung adenocarcinoma cell lines (K1 and K2) from Cdkn1aWT K-rasLA1 mice. Expression levels of the third gene of interest, LH2, are 10-30 times higher in the highly metastatic KC cells and include both LH2 isoforms, full-length (LH2b) and spliced at exon 13 (LH2a)
Manually annotated by BRENDA team
-
FUT7 mRNA remarkably highly expressed in mouse lymphoid tumor cell line TIB-63
Manually annotated by BRENDA team
-
intense immunofluorescent staining for 15-hydroxyprostaglandin dehydrogenase in macula densa and glomerulus of cyclooxygenase-2 knock-out mice
Manually annotated by BRENDA team
-
diploid FSK3 mouse mammary epithelial cells
Manually annotated by BRENDA team
-
a C57BL/6-derived methylcholantrene-induced fibrosarcoma cell line
Manually annotated by BRENDA team
-
isozymes SMS1 and SMS2
Manually annotated by BRENDA team
brain, low expression level
Manually annotated by BRENDA team
-
mRNA level of isoform Rdh10 declines during development, with strong and lasting expression in the meninges and choroid plexuses. Expression is also present in the striatum
Manually annotated by BRENDA team
monoamine oxidase A promoter is regulated by the circadian-clock components BMAL1, NPAS2, and PER2. A mutation in the clock gene Per2 in mice leads to reduced expression and activity of MAOA in the mesolimbic dopaminergic system
Manually annotated by BRENDA team
-
embryoid bodies made of MG1.19 cells. PILSAP is highly expressed at the beginning of the observed period (day 3), decreased thereafter, and increases again through day 10
Manually annotated by BRENDA team
inner medullary collecting duct 3 cell
Manually annotated by BRENDA team
-
type II lung epithelial cell
Manually annotated by BRENDA team
-
a mammary adenocarcinoma cell line
Manually annotated by BRENDA team
-
mouse mammary tumour cell
Manually annotated by BRENDA team
-
MOPC 315
Manually annotated by BRENDA team
-
renal proximal tubular epithelial cell line. CYP27B1 gene expression is elevated in response to parathyroid hormone. High Ca2+ exposure represses CYP27B1 gene expression in both dose and time-dependent fashion
Manually annotated by BRENDA team
-
a vasopressin-responsive cell culture model of cortical collecting duct, proteomic analysis of cytoplasmic fractions from mpkCCD cells, overview
Manually annotated by BRENDA team
-
immortal mpkCCDc14 cell line, derived from transgenic mice
Manually annotated by BRENDA team
-
wild-type mouse embryonic fibroblasts
Manually annotated by BRENDA team
-
immortalized mouse fibroblasts lacking topoisomerase IIbeta
Manually annotated by BRENDA team
-
high expression
Manually annotated by BRENDA team
skeletal muscle stem cell
Manually annotated by BRENDA team
-
prostate tumor cell line
Manually annotated by BRENDA team
-
isozymes SMS1 and SMS2
Manually annotated by BRENDA team
-
high level of expression
Manually annotated by BRENDA team
-
of somites
Manually annotated by BRENDA team
-
glial cell line
Manually annotated by BRENDA team
-
N2a cells stably expressing the vector pEGFP
Manually annotated by BRENDA team
-
N2a cells stably expressing human amyloid prepcursor protein Swedish mutation
Manually annotated by BRENDA team
-
TCAP-1-responsive hypothalamic cell line
Manually annotated by BRENDA team
-
microglial cell
Manually annotated by BRENDA team
NAA10 expression decreases with the induction of differentiation in NB4 cells, but the level of NAA11 remains unchanged
Manually annotated by BRENDA team
AOH2 and AOH3
Manually annotated by BRENDA team
-
all 9 membrane-associated adenylate cyclases
Manually annotated by BRENDA team
-
under resting conditions, Neu 7 astrocytes exhibit a high basal level of stellation, protease activated receptors PAR1 and PAR2 cause a significant reversal of astrocyte stellation
Manually annotated by BRENDA team
-
from A/J mice
Manually annotated by BRENDA team
of the neural tube of 10-day-old embryos
Manually annotated by BRENDA team
-
pituicytes
Manually annotated by BRENDA team
-
non-neuronal cholinergic cell
Manually annotated by BRENDA team
-
no significant differences of ChAT activity are measured at both 19 and 24 months of age between Ts65Dn mice and normogenic animals
Manually annotated by BRENDA team
-
selectively expressed in Bowman's glands
Manually annotated by BRENDA team
-
isozyme GC-D is exclusively expressed in the olfactory neuroepithelium in rodents
Manually annotated by BRENDA team
-
and vibrissae follicles, expression of isoform Rdh10 from early stages in regions where sensory receptors appear and mesenchymal/epithelial interactions take place
Manually annotated by BRENDA team
-
keratinocytes in tongue, hard palate, bucca, gingiva, and lip
Manually annotated by BRENDA team
-
in the oral cavity, strong reactivity for KLK7 in orthotopic murine tumors, immunohistochemical analysis, overview
Manually annotated by BRENDA team
-
light-dependent localizations of the transducin-alpha subunit Gtalpha
Manually annotated by BRENDA team
-
glandular stomach
Manually annotated by BRENDA team
-
a pancreatic cancer cell line
Manually annotated by BRENDA team
-
acinar cell during embryogenesis, endocrinic cell and exocrinic cell in adult
Manually annotated by BRENDA team
-
highest expression
Manually annotated by BRENDA team
-
pepsin-secreting, in the basal part of the stomach, only LOX, no LOXL
Manually annotated by BRENDA team
Q3UIK4 AND Q8C3P7
-
Manually annotated by BRENDA team
enzyme expression during bone development
Manually annotated by BRENDA team
(PEC) isolated from naive C57BL/6 mice of from lipopolysaccharide-treated mice
Manually annotated by BRENDA team
-
pheochromocytomas are tumors of adrenal chromaffin cells. Phenylethanolamine N-methyltransferase mRNA levels are markedly increased by glucocorticoid administration. Dexamethasone elicites approximately 800fold increases in phenylethanolamine N-methyltransferase mRNA levels in mouse pheochromocytoma 862L cells and approximately 75fold increases for mouse pheochromocytoma 10/9CR1 cells. Glial cell line-derived neurotrophic factor and cpt-cAMP alone each produce little or no change in baseline phenylethanolamine N-methyltransferase mRNA levels. In both cell lines, dexamethasone-stimulated increases in phenylethanolamine N-methyltranferase mRNA levels are reduced approximately 90% by prior tratment with cAMP. Glial cell line-derived neurotrophic factor reduces dexamethasone effects on phenylethanolamine N-methyltransferase mRNA levels by 40% in mouse pheochromocytoma 862L cells, while not supressing the dexamethasone response in mouse pheochromocytoma 10/9CRC1 cells. Pretreatment with cAMP and afterwards treatment with glial cell line-derived neurotrophic factor before additon of dexamethasone reduced phenylethanolamine N-methyltransferase expression in mouse pheochromocytoma 862L and 10/9CRC1 cells to 0.1% and 5.5% of their corresponding DEX induced maxima.
Manually annotated by BRENDA team
an immortalized epididymal cell line, quantitative enzyme expression analysis, overview
Manually annotated by BRENDA team
MICAL2 expression increases during myogenic differentiation of adult and pluripotent stem cells
Manually annotated by BRENDA team
-
cathepsin H is highly expressed in the secretory organelles of alveolar type II pneumocytes
Manually annotated by BRENDA team
-
FL5.12
Manually annotated by BRENDA team
CYLD is drastically upregulated during RANKL-induced differentiation of preosteoclasts
Manually annotated by BRENDA team
-
ESR-586, grown subcutaneously
Manually annotated by BRENDA team
-
higher enzyme activity than in F9 EC cells
Manually annotated by BRENDA team
-
transgenic animals
Manually annotated by BRENDA team
TMPRSS2 protease is highly expressed in metastatic prostate cancers
Manually annotated by BRENDA team
-
endothelial cell line
Manually annotated by BRENDA team
-
microglial cell line
Manually annotated by BRENDA team
-
derived from monocyte/macrophage cell line RAW 264.7
Manually annotated by BRENDA team
P21958 AND P36371
-
Manually annotated by BRENDA team
-
of human and rat but not in guinea pig, cattle, goat or pig
Manually annotated by BRENDA team
-
the enzyme is mainly found in proximal tubules, localized inside the tubular epithelial cells
Manually annotated by BRENDA team
-
tumor-induced dysregulation of endocytic activity of dendritic cells is mediated by reduced activity of several members of the small Rho GTPase family
Manually annotated by BRENDA team
P21958 AND P36371
-
Manually annotated by BRENDA team
-
strong expression in adult
Manually annotated by BRENDA team
-
cultured T-lymphoma cells
Manually annotated by BRENDA team
-
expression in in both the epithelial and stromal elements, low enzyme activity
Manually annotated by BRENDA team
3LL carcinoma and T10 sarcoma, overexpression of PDGF-alpha receptor in high-metastatic clones
Manually annotated by BRENDA team
-
isolated from skeletal muscle
Manually annotated by BRENDA team
-
a hypothalamic neuronal cell line
Manually annotated by BRENDA team
-
strong expression in adult
Manually annotated by BRENDA team
METTL21C is exclusively expressed in slow MYH7-positive skeletal muscle fibers
Manually annotated by BRENDA team
low amounts of NOX3
Manually annotated by BRENDA team
-
adenylosuccinate synthetase expression is downregulated in SM-5 cells
Manually annotated by BRENDA team
-
adenylosuccinate synthetase expression is downregulated in SM-7 cells
Manually annotated by BRENDA team
dopaminergic cells
Manually annotated by BRENDA team
spermatogonial, somatic ACE (sACE), but not testicular ACE (tACE), is expressed in mouse cultured spermatogonial stem cells (SSCs)
Manually annotated by BRENDA team
consistent with having a role in the growth of MAP2-positive neurites, TTLL7 accumulates within a MAP2-enriched somatodendritic portion of superior cervical ganglion, as does polyglutamylated beta-tubulin
Manually annotated by BRENDA team
-
expressed in sustentacular cells of the olfactory epithelium but not, or much less, in most olfactory receptor neurons
Manually annotated by BRENDA team
-
colon, uterus
Manually annotated by BRENDA team
-
endothelial cell line
Manually annotated by BRENDA team
-
Beko cell, spontaneous T-cell lymphoma cell line derived from T-cell receptor beta knockout mice, only KDM5A and KDM5C are expressed
Manually annotated by BRENDA team
-
TGFalpha-transfected mouse hepatocyte cell line
Manually annotated by BRENDA team
-
submedial thalamic nucleus
Manually annotated by BRENDA team
-
adenylosuccinate synthetase expression is downregulated in thymic lymphoma cells
Manually annotated by BRENDA team
only in jaw containing the developing tooth buds appreciable levels of the enzyme
Manually annotated by BRENDA team
-
localized predominantly to the extracellulat matrix of chondrocytes and to primary trabeculae of the skeleton
Manually annotated by BRENDA team
-
prostate tumor cell line
Manually annotated by BRENDA team
motor trigeminal nucleus
Manually annotated by BRENDA team
paravertebral trunk of the sympathetic nervous system
Manually annotated by BRENDA team
low mRNA expression
Manually annotated by BRENDA team
-
proliferating cell, LOXL expression, adult tissues
Manually annotated by BRENDA team
-
induced thrombus
Manually annotated by BRENDA team
-
ventral palladium, approximately 60% of cannabinoid-1 receptor-labeled axonal profiles oppose or converge with axon terminals containing N-acylphosphatidylethanolamine-hydrolyzing phospholipase D immunoreactivity
Manually annotated by BRENDA team
high expression level
Manually annotated by BRENDA team
-
restricted mesenchymal and epithelial regions. Its localization and strength changes during the hair cycle. Activity in the dermal papilla is moderate in very early anagen, reaches a maximal level in early anagen, decreases at the proximal region of dermal papilla after mid anagen, and is kept at a low level during catagen. The bulbar dermal sheath shows intense alkaline phosphatase activity only in early anagen. Most bulbar epithelium does not show alkaline phosphatase activity, germinative epidermal cells that are adjacent to the alkaline phosphatase-negative dermal papilla cells become alkaline phosphatase-positive in mid anagen and rearrange in a single layer so as to encapsulate the dermal papilla in mid catagen. During catagen, the outermost layer of bulbar epithelium becomes alkaline phosphatase-positive, which could be follicular epithelial precursors migrating from the bulge. Before the initiation of hair formation, alkaline phosphatase activity in the bulbar epithelium rapidly decreases and that in dermal papilla increases. These dynamic changes of alkaline phosphatase expression might be related to functions of the dermal papilla in hair induction and also to reconstruction of the bulbar structure during the hair cycle
Manually annotated by BRENDA team
-
high activity
Manually annotated by BRENDA team
-
intense immunoreactivity
Manually annotated by BRENDA team
-
murine thymic lymphoma cells
Manually annotated by BRENDA team
sEH is highly expressed throughout the body
Manually annotated by BRENDA team
wild-type bone-marrow-derived macrophage cells
Manually annotated by BRENDA team
-
mouse lymphoma cell
Manually annotated by BRENDA team
-
the level of the enzyme in theses cells decreases as the cells differentiate
Manually annotated by BRENDA team
-
YT 5 cell
Manually annotated by BRENDA team
additional information